Literatur-Liste

In diesem Abschnitt finden Sie einige ausgewählte Publikationen zum Thema Omega-3-Fettsäuren. Wir werden die Liste stetig ergänzen.

Literatur zu Omega-3-Fettsäuren: Stoffwechsel, Wirkungen und allgemeine Gesichtspunkte

Koch E., Kampschulte N., Schebb N.H. (2022): Comprehensive analysis of fatty acid and oxylipin patterns in n3-PUFA supplements. J Agric Food Chem 70:3979-3988
Esselun C., Dieter F., Sus N., Frank J., Eckert G.P. (2022): Walnut oil reduces Aβ levels and increases neurite length in a cellular model of early Alzheimer disease. Nutrients 14:1694
Schebb N. H., Kühn H., Kahnt A. S., Rund K. M., O` Donnell V. B., Flamand N., Peters – Golden M. et.al. (2022): Formation, signaling and occurrence of specialized pro-resolving lipid mediators – What is the evidence so far ? Front Pharmacol 13: 838782
Mc Burney M. I., Tintle N.L., Harris W.S. (2022): The omega-3-index is inversely associated with the neutrophil-lymphocyte ratio in adults. Prostaglandins Leucot Essent Fatty Acids 177: 102397
Mc Burney M. I., Tintle N. L., Harris W.S. (2022): Omega-3 index is directly associated with a healthy red blood cell distribution width. Prostaglandins Leukot Essent Fatty Acids 176:102376
Jo S., Harris W. S., Tintle N. L., Park Y. (2022): Association between omega-3 index and hyperglycemia depending on body mass index among adults in the United States. Nutrients 14: 4407
Carballo- Casla A., Garcia-Esquinas E., Banegas J. R., Rodriguez- Artalejo F., Ortola R. (2022): Fish consumption, omega-3 fatty acid intake, and risk of pain: the Seniors-ENRICA-1 cohort. Clin Nutr 41: 2587-2595
Ogluszka M., Lipinski P., Starzynski R.R. (2022): Effect of omega-3 fatty acids on teomeres –are they the elixir of youth? Nutrients 14: 3723
Best K. P., Gibson R.A., Makrides M. (2022): ISSFAL statement number 7- Omega-3 fatty acids during pregnancy to reduce preterm birth. Prostaglandins Leukot Essent Fatty Acids 186:103495
Fisk H. L., Childs C. E., Miles E. A., Ayres R., Noakes P.S., Paras-Chavez C., Antoun E. et.al. (2022): Dysregulation of subcutaneous white adipose tissue inflammatory environment modelling in non-insulin resistant obesity and responses to omega-3 fatty acids – a double blind , randomised clinical trial. Front Immunol 13: 922654
Zhang Y., Guo H., Liang J., Xiao W., Li Y. (2022): Relationship between dietary omega-3 and omega-6 polyunsaturated fatty acids level and sarcopenia. A meta-analysis of observational studies. Front Nutr 8: 38083
Gkiouras K., Grammaticopoulou M. G., Myrogiannis I., Papamitsou T., Rigopoulou E I., Sakkas L., Bogdanos D. P. (2022): Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis disease activity indicators: A systematic review and meta- analysis of randomized placebo-controlled trials. Crit Rev Food Sci Nutr 28:1-15
Dos Santos N. C. C., Furukawa M. V., Oliveira-Cardoso I., Cortelli J.R., Feres M.,Van Dyke T., Rovai E. S. (2022): Does the use of omega-3 fatty acids as an adjunct to non-surgical periodontal therapy provide additional benefits in the treatment of periodontitis? A systematic review and meta-analysis. J Peridontal Res 57: 435-447
Takic M., Pokimica B., Petrovic- Oggiano G., Popovic T. (2022): Effects of dietary α-linolenic acid treatment and the efficiency of its conversion to eicosapentaenoic and docosahexaenoic acids in obesity and related disease. Molecules 27: 4471
Tingö L., Hutchinson A. N., Bergh C., Stiefvatter L., Schweinlin A., Jensen M.G., Krüger K. (2022): Potential modulation of inflammation by probiotic and omega – 3 supplementation in elderly with chronic low – grade inflammation – a randomized , placebo – controlled trial. Nutrients 14:3998
Djuricic I., Calder P. C. (2022): Polyunsaturated fatty acids and metabolic health: novel insights. Curr Opin Clin Nutr Metab Care 25:436–442
Dube L., Spahis S., Lachaine K., Lemieux A., Monhem H., Poulin S-M., Randoll C. et.al. (2022): Specialized pro – resolving mediators derived from n-3 polyunsaturated fatty acids: role in metabolic syndrome and related complications. Antioxid Redox Signal 37: 54–83
Tan L-J., Shin S. ( 2022): Effects of oily fish and fatty acid intake on non-alcoholic liver disease development among South Korean adults. Front Nutr 22:876909
Smid V., Dvorak K., Sedivy P., Kosek V., Lenicek M., Dezortova M., Hajslova J.et.al. (2022): Effect of omega – 3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome NAFLD. Hepatol Commun 6:1336–2349
Itoh S., Nagao Y., Morita K., Kurihara T., Tomino T., Kosai-Fujimoto Y., Harada N.et.al. (2022): Association between sarcopenia and omega – 3 polyunsaturated fatty acid in patients with hepatocellular carcinoma. JMA J 5:169–176
Tojo T., Tsuruoka M., Kondo T., Yuasa M. (2022): Evaluation of cancer cell growth suppressibility of ω – 3 fatty acids and their metabolites. J Oleo Sci 71:1253–1260
Yin H., Liu Y., Yue H., Tian Y., Dong P., Xue C., ZhaoY-T.et.al. (2022): DHA – and EPA – enriched phosphatidylcholine suppress human lung carcinoma 95D cells metastasis via activating the peroxisome proliferator – activated receptor ϒ. Nutrients 14:4675
Lampova B., Doskocil I., Kourimska L.,Kopec A. ( 2022): N -3 polyunsaturated fatty acids may affect the course of COVID–19. Frontiers Immunology 13:957518
Taha A. M., Shaarawy A. S., Omar M. M., Abouelmagd K., Shalma N. M., Alhashemi M., Ahmed H. M. et al. (2022): Effect of omega -3 fatty acids supplementation on serum level of C – reactive protein in patients with COVID – 19 : a systematic review and meta – analysis of randomized controlled trials. J Transl Med 20: 401
Ramirez -Santana M., Barra R. Z., Gonzalez M. N., Müller J. M., Vasquez J. E., Ravera F., Lago G. et al. (2022): Inverse association between omega – 3 index and severity of COVID-19: A case – control study. Int J Environ Res Public Health19: 6445
Mazidimoradi A., Alemzadeh E., Alemzadeh E., Salehiniya H. (2022): The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: a systematic review. Life Sci 299:120489
Goc A., Niedzwiecki A., Rath M. ( 2021): Polyunsaturated ω – 3 fatty acids inhibit ACE2 – controlled SARS – CoV -2 binding and cellular entry. Sci Rep 11:5207 Zaloga G. P. (2021): Narrative review of n-3 polyunsaturated fatty acid supplementation upon immune functions, resolution molecules and lipid peroxidation. Nutrients 13: 662
Singer P., Richter V., Singer K., Löhlein I. (2021): Analyses and declarations of fatty acids in canned seafood may help to quantify their dietary intake. Nutrients 13:2970
Richter V., Blüher M. (2021): Sarkopenie, Adipositas und kardiovaskuläre Erkrankungen im hohen Lebensalter – Welche Rolle spielt die Ernährung ? Perfusion 34: 68-81
Asher A., Tintle N.L., Myers M., Locksohn L., Bacareza H., Harris W.S. (2021): Blood omega-3 fatty acids and death from COVID-19: A pilot study. Prostaglandins Leukot Essent Fatty Acids 166:102250
Goc A., Niedzwiecki A., Rath M. (2021): Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci Rep 11:5207
Simopoulos A.P. (2021): Genetic variation, diet, inflammation, and risk for COVID-19. Lifestyle Genom. 14:37-42
Powell N., Chaudharry S., Zaidi A (2021): It is time for an oil change: Polyunsaturated fatty acids and human health. Mo Med 118:426-430
Li J., Pora B.L.R., Dong K., Hasjim J. (2021): Health benefits of docosahexaenoic acid and its bioavailability: A review. Food Sci Nutr 9: 5229- 5243
Ma M-Y., Li K-L., Zheng H., Dou Y-L., Han L-Y., Wang L. (2021): Omega-3 index and type 2 diabetes: Systematic review and meta-analysis. Proataglandins Leukot Essent Fatty Acids 174: 102361
Xin G., Eshaghi H. (2021): Effect of omega-3 fatty acids supplementation on indirect blood markers of exercise- induced muscle damage: Systematic review and meta-analysis of randomized controlled trials. Food Sci Nutr 9: 6429-6442
Kotronoulas A., de Lomana A.L.G., Karvelsson S. T., Heijink M., Stone li R., Giera M., Rolfsson O.(2021): Lipid mediator profiles of burn wound healing: Acellular cod fish skin grafts promote the formation of EPA and DHA derived lipid mediators following seven days of treatment. Prostaglandins Leukot Essent Fatty Acids 175: 102358
Yamaguchi A., Nishida Y., Maeshige N., Moriguchi M., Uemura M., Ma X., Miyoshi M., Kondo H., Fujino H. (2021): Preventive effect of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against endotoxin-induced muscle atrophy. Clin Nutr ESPEN 45: 503-506
Mendivil C.O. (2021): Dietary fish, fish nutrients, and immune function: A review. Front Nutr 7: 617652
Camacho-Munoz D., Kiezel-Tsugonova M., Kiss O., Uddin M., Sunden M., Ryaboshapkina M., Lind L., Oscarsson J., Nicolaou A. (2021): Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease. FASEB 35: e21976
DiNicolantonio J.J., O´Keefe J. (2021): The importance of maintaining a low omega-6/ omega -3 ratio for reducing the risk of autoimmune diseases, asthma, and allergies. Mo Med 118: 453-459
Cheng L.J., Sanguansri L., Hlaing M.M., Singh T., Shrestha P., Augustin M.A. (2021): Use of vegetables for enhancing oxidative stability of omega-3 oils on the powered state. Food Chem 370: 131340
Saleh R.N.M., West L.A., Ostermann A. I., Schebb N.H., Calder P.C., Minihane A.M. (2021): APOE genotype modifies the plasma oxylipin response to omega-3 polyunsaturated fatty acid supplementation in healthy individuals. Front Nutr 8:723813
Panchal S.K., Brown L. (2021): Addressing the insufficient availability of EPA and DHA to meet current and future nutritional demands. Nutrients 13: 2855
Ferguson E.J., Seigel J.W., McGlory C. (2021): Omega-3 fatty acids and human skeletal muscle. Curr Opin Clin Metab Care 24: 114-119
Djuricic I., Calder P.C. (2021): Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health. Nutrients 13: 2421
Isesele P.O., Mazurak V. C. (2021): Regulation of skeletal muscle satellite cell differentiation by omega-3 polyunsaturated fatty acids: A critical review. Front Physiol 12: 682091
Wang Z-G., Zhu Z-Q., He Z-Y., Cheng P., Liang S., Chen A- M., Yang Q. (2021): Endogenous conversion of n-6 to n-3 polyunsaturated fatty acids facilitates the repair of cardiotoxin-induced skeletal muscle injury in fat-1 mice. Aging 13: 8454-8466
Kutzner L., Esselun C., Franke N., Schoenfeld K., Eckert G.P., Schebb N.H.(2021): Effect of dietary EPA and DHA on murine blood and liver fatty acid profile andliver oxylipin pattern depending on high and low dietary n 6-PUFA. Food Funct 11: 9177-9191
Kutzner L., Goloshchapova K., Rund K. M., Jübermann M., Blum M., Rothe M., Kirsch S. F., Schunck W-H., Kühn H., Schebb N.H. (2020): Human lipoxygenase isoforms form complex patterns of double and triple oxygenated compounds from eicosapentaenoic acid. Biochim Biophys Acta Mol Cell Biol Lipids 1865: 158806
Leineweber C. G., Pietzner A., Zhang I.W., Blessin U.B., Rothe M., Schott E., Schebb N.H., Weylandt K.H.(2020): Assessment of the effect of sorafenic on omega-6 and omega-3 epoxyeicosanoid formation in patients with hepatocellular carcinoma. Int J Mol Sci 21: 1875 Witard O.C., Combet E., Gray S.R. (2020): Long-chain n-3 fatty acids as an essential link between musculoskeletal and cardio-metabolic health in older adults. Proc Nutr Soc 79: 47-55
von Schacky C. (2020): Omega-3 fatty acids in pregnancy – the case for a target omega-3 index. Nutrients 12: 898
Richter V., Blüher M., Thiery J., Hamm M. (2020): Multiple Effekte von Omega-3-Fettsäuren im Fettgewebe. Adipositas 14: 96-106
Jentsch H., Richter V., Hamm M. (2020): Wissen über Omega-3- Fettsäuren – Wichtig für die Parodontologie? Quintessenz Zahnmedizin 71: 528-536
Kutzner L., Goloshchapova K., Rund MK.,Jübermann M., Blum M., Kirsch SF., Schunck W-H., Kühn H., Schebb HN. (2020): Human lipoxygenase isoforms form complex patterns of double and triple oxygenated compounds from eicosapentaenoic acid. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158806
Leineweber CG., Pietzner A., Zhang IW., Blessin UB., Rothe M., Schott E., Schebb NH.,Weylandt KH. (2020): Assessment of the effect of sorafenib on omega-6 and omega-3 epoxyeicosanoid formation in patients with hepatocellular carcinoma. Int J Mol Sci. 21:1875
Weill P., Plissonneau C., Legrand P., Rioux V., Thibault R. (2020): May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie.doi.org/10.1016/j.biochi.2020.09.003
Rogero M M., de C. Leao M., Santana TM., de M.B. Pimentel MV., Carlini GCG., da Silveira TFF., Goncalves RC., Castro IA. (2020): Potential benefits and risk of omega -3 fatty acids supplementation to patients with COVID- 19. Free Radical Biology and Medicine 156:190-199
Regidor PA., Santos FG., Rizo JM., Egea FM. (2020): Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID- 19. Med Hypot 145:110340
Troesch B., Eggersdorfer M., Laviano A., Rolland Y., Smith AD., Warnke I., Weimann A., Calder PC. (2020): Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition. Nutrients12: 2555
Pradelli L., Klek S., Mayer K., Alsaleh AJO., Rosenthal MD., Heller AR., Muscaritoli M. (2020): Omega-3 fatty acid-containing parenteral nutrition in ICU patients: Systematic review with meta-analysis and cost-effectiveness analysis. Crit Care 24:634
Alberti G., Gana JC., Santos JL. (2020): Fructose, omega3 fatty acids, and vitamin E: Involvement in pediatric non-alcoholic fatty liver disease. Nutrients 12:3531
Pastor R., Tur JA. (2020): Response to exercise in older adults who take supplements of antioxidants and/or omega-3 polyunsaturated fatty acids: A systematic review. Biochem Pharmacol.173:113649
Lee JH., Jeon HJ., Lee MJ. (2020): Docohexaenoic acid , a potential treatment for sarcopenia, modulates the ubiquitin-proteasome and autophagy-lyosome systems. Nutrients12: 2597
Rondanelli M., Rigon C., Perna S., Gasparri C., Ianello G., Akber R., Alalwan TA., Freije AM. (2020): Novel insights on intake of fish and prevention of sarcopenia: All reasons for an adequate consumption. Nutrients 12: 307
Liu R., Chen Y., Wang Y., Zhang G., Cheng Y., Feng Z., Bai X., Liu J. (2020): High ratio of ω-3/ω-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice. Nutr Biochem. 79:108330
Stando M., Piatek P., Namiecinska M., Lewkowicz P., Lewkowicz N. (2020): Omega -3 polyunsaturated fatty acids EPA and DHA as an adjunct to non-surgical treatment of periodontitis: A randomized clinical trial. Nutrients 12: 2614
Kruse AB., Kowalski Cd., Leuthold S., Vach K., Ratka-Krüger P., Woelber JP. (2020): What is the impact of the adjunctive use of omega – 3 fatty acids in the treatment of periodontitis? A systematic review and meta- analysis. Lipids in Health and Disease 19:100
Tachtsis B., Whitfield J., Hawley JA., Hoffman NJ. (2020): Omega -3 polyunsaturated fatty acids mitigate palmitate-induced impairments in skeletal muscle cell viability and differentiation. Front Physiol. 11:563
Hutchinson AN., Tingö L., Brummer RJ. (2020): The potential effects of probiotics and ω-3 fatty acids on chronic low-grade inflammation. Nutrients 12:2402
Kostoglou- Athanassiou I., Athanassiou L., Athanassiou P. (2020): The effect of omega-3 fatty acids on rheumatoid arthritis. Mediterr J Rheumatol. 31(2):190-194
Lanchais K., Capel S., Tournadre A. (2020): Could omega 3 fatty acids preserve muscle health in rheumatoid arthritis? Nutrients 12: 223
Lee C-H., Fu Y., Yang S-J., Chi C-C. (2020): Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: A systematic review and meta- analysis. Nutrients 12:2769
Barman M., Rabe H., Hesselmar B., Johansen S., Sandberg A-S., Wold AE. (2020): Cord blood levels of EPA, a marker of fish intake, correlate with infants T- and B- lymphocyte phenotypes and risk for allergic disease. Nutrients 12:3000
Lozano- Munoz I., Munoz S., Diaz NF., Medina A., Bazaes J., Riquelme C. (2020): Nutritional enhancement of farmed salmon meat vie non-GMO nannochloropsis gaditana: Eicosapentaenoic acid (EPA, 20:5 n-3), docosapentaenoic acid (DPA, 22:5 n-3) and vitamin D3 for human health. Molecules 25: 4615
Ramalho T., Pahlavani M., Kalupahana N., Wijayatunga N., Ramalingam L., Jancar S., Moustaid-Moussa N. (2020): Eicosapentaenoic acid regulates inflammatory pathways through modulation of transcripts and miRNA in adipose tissue of obese mice. Biomolecules10:1292
Menozzi D., Nguyen TT., Sogari G., Taskov D., Lucas S., Castro-Rial JLS., Mora C. (2020): Consumers preferences and willingness to pay for fish products with health and environmental labels: Evidence from five European countries. Nutrients 12:2650
Rao A., Briskey D., O Nalley J.,Ganuza E. (2020): Omega-3 eicosapentaenoic acid (EPA) rich extract from the microalga Nannochloropsis decreases cholesterol in healthy individuals: A double-blind, randomized, placebo-controlled, three-month supplementation study. Nutrients 12:1869
Wardle SL., Macnaughton LS., McGlory C., Witard OC., Dick JR., Whitfield PD., Ferrando AA., Wolfe RR., Kim I-Y., Hamilton DL., Moran CN., Tipton KD., Galloway SDR. (2020): Human skeletal muscle metabolic responses to 6 days of high-fat overfeeding are associated with dietary n-3PUFA content and muscle oxidative capacity. Physiol Rep Doi.org/10.14814/phy2.14529
Nguyen QV., Malau-Aduli BS., Cavalieri J., Malau-Aduli AEO.,Nichols PD. (2019): Enhancing omega-3 long-chain polyunsaturated fatty acid content of dairy-derived foods for human consumption. Nutrients11: 743 Greupner T., Koch E., Kutzner L., Hahn A., Schebb NH., Schuchardt JP. (2019): Single-dose SDA-rich echium oil increases plasma EPA, DPA n 3; and DHA concentrations. Nutrients11: 2346
Ostermann AI., West AL., Schoenfeld K., Browning LM., Walker CG., Jebb SA., Calder PC., Schebb NH. (2019): Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Am J Clin Nutr 109: 1251-1263
Jentsch H., Blüher M., Hamm M., Thiery J., Richter V. (2019): Paradontitis – Adipositas – Atherosklerose. Zusammenhänge und Einfluss der Ernährung. Paradontologie 30: 23-36
Hartung NM., Fischer J., Ostermann Al., Willenberg I., Rund KM., Schebb NH., Garscha U. (2019): Impact of food polyphenols on oxylipin biosynthesis in human neutrophils. Biochim Biophys Acta Mol Cell Biol Lipids 1864: 1536-1544
Derbyshire E. (2019): Oily fish and omega-3s across the life stages: A focus on intakes and future directions. Frontiers Nutr 6: Article 165
Herter-Aeberli I., Graf C., Vollenweider A., Häberling I., Srikanthan P., Hersberger M., Berger G., Mathis D. (2019): Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in Switzerland. Nutrients 11: 1863
Hirakata T., Yokomizo T., Matsuda A. (2019): The roles of omega-3 fatty acids and resolvins in allergic conjunctivitis. Curr Opin Allergy Clin Immunol 19: 517-525
AlAmmar WA., Albeesh FH.,Ibrahim LM., Algindan YY., Yamani LZ., Khattab RY. (2019): Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci 28: 1-11
Cao JJ., Gregoire BR., Michelsen KG., Picklo MJ. (2019): Increasing dietary fish oil reduces adiposity and mitigates bone deterioration in growing C57BL/6 mice fed a high- fat diet. J Nutr 11: doi:10.1093/jn/nxz215
Asbaghi O., Choghakhori R., Abbasnezhad A. (2019): Effect of omega-3 and vitamin E co-supplementation on serum lipids concentrations in overweight patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 13: 2525-2531
Kendall AC., Pilkington SM., Murphy SA., Del Carratore F., Sunarwidhi AL., Kiezel-Tsugunova M., Urquhart P.,Watson REB., Breitling R., Rhodes LE., Nikolaou A. (2019): Dynamics of the human skin mediator lipidome in response to dietary ω-3 fatty acid supplementation. FASEB J 13:fj201901501R doi: 10.1096/fj.201901501R
Ruyter B., Sissener NH., Ostbye TK.,Simon CJ., Krasnov A., Bou M., Sanden M., Nichols PD., Lutfi E., Berge GM. (2019): Omega-3 canola oil effectively replaces fish oil as a new safe dietary source of docosahexaenoic acid (DHA) in feed for juvenile Atlantic salmon. Br J Nutr 11: 1-43
Li D., Wahlqvist ML., Sinclair AJ. (2019): Advances in n-3 polyunsaturated fatty acid nutrition. Asia Pac J Clin Nutr 28: 1-5
Sung HH., Sinclair AJ., Huynh K., Smith AT., Mellett NA., Meikle PJ., Su XQ. (2019): Differential plasma postprandial lipidomic responses to krill oil and fish oil supplementations in women: a randomized crossover study. Nutrition 65: 191-201
Golzari Mh., Javanbakht Mh.,Ghaedi E., Mohammadi H., Djalali M. (2019): Effect of eicosapentaenoic acid supplementation on paraoxonase 2 gene expression in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Clin Nutr Res 8: 17-27
Anzalone A., Carbuhn A., Jones L., Gallop A., Smith A., Johnson P., Swearingen L., Moore C., Rimer E., McBeth J., Harris W., Kirk KM., Gable D., Askow A., Jennings W., Oliver JM. (2019): The omega-3 index in national collegiate athletic association division I collegiate football athletes. J Athl Train 54: 7-11
Hudek R., von Schacky C., Passow A., Abdelkawi AF., Werner B., Gohlke F. (2019): Degenerative rotator cuff tears are associated with a low omega-3 index. Prostaglandins Leucot Essent Fatty Acids 148: 35-40
McGlory C., Calder PC., Nunes EA. (2019): The influence of omega-3 fatty acids on skeletal muscle protein turnover in health, disuse, and disease. Front Nutr 6: 144. doi: 10.3389/fnut.2019.00144
Greupner T., Kutzner L., Nolte A., Strangmann F., Kohrs H., Hahn A., Schebb NH., Schuchardt JP. (2018): Effects of a 12-weeks high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status. Food Funct 9: 1587-1600
Sung HH., Sinclair AJ., Lewandowski PA., Su XQ. (2018): Postprandial long-chain n-3 polyunsaturated fatty acid response to krill oil and fish oil consumption in healthy women: a randomised controlled, single-dose, crossover study. Asia Pac J Clin Nutr 27:148-157
Krishnamoorthy N., Abdulnour R-E E., Walker KH., Engstrom BD., Levy BD. (2018): Specialized proresolving mediators in innate and adaptive immune responses in airway disease. Physiol Rev 98:1335-1370
Navarini L., Bisogno T., Margiotta DPE.,Piccoli A., Angeletti s., Laudisio A., Ciccozzi M., Afeltra A., Maccarrone M. (2018): Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results. J Immunol Res 2018:5264195. doi: 10. 1155/2018/5264195
Harris WS. (2018): The omega-3 ratio: a critical appraisal and possible successor. Prostaglandins Leukot Essent Fatty Acids 132: 34-40
Rund KM., Ostermann AI., Kutzner L., Galano JM., Oger C., Vigor C., Wecklein S., Seiwert N., Durand T., Schebb NH. (2018): Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6- PUFAs. Anal Chim Acta 1037: 63-74 Bazan NG. (2018): Docosanoids and elovanoids from omega-3 fatty acids are prohomeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol Aspects Med 64:18-33
Schuchardt JP., Ostermann AI., Stork L., Fritsch S., Kohrs H., Greupner T., Hahn A., Schebb NH. (2017): Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood. Prostaglandins Leukot Essent Fatty Acids 121:76 – 87
Kutzner NL., Goloshchapova K., Heydeck D., Stehling S., Kuhn H., Schebb NH. (2017): Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid. Biochim Biophys Acta 1862: 666 – 675
Köhler A., Heinrich J., von Schacky C. (2017): Bioavailability of dietary omega – 3 fatty acids added to a variety of sausages in healthy individuals. Nutrients 9: 629
Richter V., Blüher M., Thiery J., Hamm M. (2017): Omega-3 – Fettsäuren und Adipositas im Kinder – und Jugendalter. Kinder –und Jugendmedizin 17: 43 – 47
Jentsch H., Richter V., Hamm M. (2017): Stellenwert von Omega-3 – Fettsäuren in der Prävention und Therapie der Paradontitis. Paradontol 28: 399 – 408
Nettleton JA., von Schacky C., Brouwer IA., Koletzko B. (2017): International Society for the Study of Fatty Acids andLipids 2016 debate: for science- based dietary guidelines on fats , meta – analysis and systematic reviews are decisive. Ann Nutr Metab 71: 26 – 30
Kutzner L., Ostermann AI., Konrad T., Riegel D., Hellhake S., Schuchardt JP., Schebb NH. (2017): Lipid class specific quantitative analysis of n – 3 polyunsaturated fatty acids in food supplements. J Agric Food Chem 65: 139 – 147
Gellert S., Schuchardt JP., Hahn A. (2017): Low long chain omega – 3 fatty acid status in middle – aged women. Prostaglandins Leukot Essent Fatty Acids 117: 54 – 59
Gao., Geng T., Huang T., Zhao Q. (2017): Fish oil supplementation and insulin sensitivity: a systematic review and meta – analysis. Lipids Health Dis. 16: 131
Kuda O. (2017): Bioactive metabolites of docosahexaenoic acid. Biochimie136: 12 – 20
Ostermann AI., Schebb NH. (2017): Effects of omega – 3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy – , dihydroxy – , and epoxy – fatty acids. Food Funct 8: 2355 – 2367
Rodriguez – Cruz M., Serna DS. (2017): Nutrigenomics of ω – 3 fatty acids: regulators of the master transcription factors. Nutr 41: 90 – 96
Miles EA., Calder PC. (2017): Can early omega – 3 fatty acid exposure reduce risk of childhood allergic disease? Nutrients 9: pii E784
Zarate R., El Jaber–Vazdekis N., Tejera N., Perez JA., Rodriguez C. (2017): Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med 6: 25
Norling LV., Ly L., Dalli J. (2017): Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators. Curr Opin Clin Metab Care 20: 145 – 152
Helland A., Bratlie M., Hagen IV., Mjos SA., Sornes S., Ingvar Halstensen A., Brokstad KA., Sveier H., Rosenlund G., Mellgren G., Gudbransen OA. (2017): High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n- 3 PUFA content in the leucocyte membrane in healthy overweight adults: a randomized trial. Br J Nutr 117: 1368 – 1378
Wan Y., Zheng J., Wang F., Li D. (2017): Fish, long chain omega- 3 – polyunsaturated fatty acids consumption, and risk of all – cause mortality: a systematic review and dose – response meta – analysis from 23 independent prospective cohort studies. Asia Pac J Clin Nutr 26: 939 – 956
Hu XF., Sandhu SK., Harris WS., Chan HM. (2017): Conversion ratios of n – 3 fatty acids between plasma and erythrocytes: a systematic review and meta – regression. Br J Nutr 117: 1162 – 1173
Thuppal SV., von Schacky C., Harris WS., Sherif KD., Denby N., Steinbaum SR., Haycock B., Bailey RL.(2017): Discrepancy between knowledge and perceptions of dietary omega – 3 – fatty acid intake compared with the omega – 3 index. Nutrients 9: pii E930
Cheng H., Wang W., Hong C., Zhang M., Hong Y., Wang S., Zhang H. (2017): Omega – 3 fish oil reduces mortality due to severe sepsis with acute gastrointestinal injury grade III. Pharmacog Mag 13: 407 – 412
Chauhan S., Kodali H., Noor J., Ramteke K., Gawai V. (2017): Role of omega – 3 fatty acids on lipid profile in diabetic dyslipidaemia: single blind, randomized clinical trial. J Clin Diagn Res 11: OC13-OC16
Menni C., Zierer J., Pallister T., Jackson M.A., Long T., Mohney R.P., Steves C J., Spector T.D., Valdes A.M. (2017): Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women. Sci Rep 7:11079
Lopez – Vicario C., Rius B., Alcaraz – Quiles J., Garcia – Alonso V., Lopategi A., Titos E., Claria J. (2016): Pro – resolving mediators produced from EPA and DHA: overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. Eur J Pharm 785: 133 – 143
Singer P., Wirth M., Singer K. (2016): Canned seawater fish with declared content of omega – 3 fatty acids: a novel benefit for dietary practice and research. Eur J Clin Nutr 70: 1093-1094
Weylandt KH. (2016): Docosapentaenoic acid derived metabolites and mediators – The new world of lipid mediator medicine in a nutshell. Eur J Pharmacol 785: 108 – 115
Cicero AFG., Rosticci M., Morbini M., Cagnati M., Grandl E., Parini A., Borghi C. (2016): Lipid – lowering and anti – inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross- over , clinical trial. Arch Med Sci 12: 507 – 512
Barden AE., Mas E., Mori TA. (2016): n – 3 fatty acid supplementation and proresolving mediators of inflammation. Curr Opin Lipidol 27: 26 – 32
Polus A., Zapala B., Razny U., Gielicz A., Kiec – Wilk B., Malczewska – Malec M., Sanak M., Childs CE., Calder PC., Dembinska – Kiec A. (2016): Omega – 3 fatty acid supplementation influences the whole blood transcriptome in women with obesity , associated with pro – resolving lipid mediator production. Biochim Biophys Acta 1861: 1746 – 1755
Allaire J.,Couture P., Leclerc M., Charest A., Marin J., Lepine M – C., Talbot D., Tchernof A., Lamarche B. (2016): A randomized, crossover, head – to – head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (Compar ED) study. Am J Clin Nutr 104: 280 – 287
Raatz SK., Johnson LK., Rosenberger TA., Picklo MJ. (2016): Twice weekly intake of farmed Atlantic salmon ( Salmo salar) positively influences lipoprotein concentration and particle size in overweight men and women. Nutr Res 36: 899 – 906
Moro K., Nagahashi., Ramanathan R., Takabe K., Wakai T. (2016): Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases 4: 155 – 164
Sorokin AV., Yang ZH., Vaisman BL., Thacker S., Yu ZX., Sampson M., Serhan CN., Remaley AT. (2016): Addition of aspirin to a fish oil – rich diet decreases inflammation and atherosclerosis in ApoE – null mice. J Nutr Biochim 35: 58 – 65
Mozurkewich EL., Greenwood M., Clinton C., Berman D., Romero V., Djuric Z., Qualls C., Gronert K. ( 2016): Pathway markers for pro – resolving lipid mediators in maternal and umbilical cord blood: a secondary analysis of the mothers, omega – 3, and mental health study. Frontiers in Pharmacol 7:1 – 8
Stark KD., Van Elswyk ME., Higgins MR., Weatherford CA., Salem N Jr. (2016): Global survey of the omega – 3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 63: 132 – 152
Hennebelle M., Courchesne – Lover A., St Pierre V., Vandenberghe C., Castellano CA., Fortier M., Tessier D., Cunnane SC. (2016): Preliminary evaluation of a differential effect of an α – linolenate – rich supplement on ketogenesis and plasma ω – 3 fatty acids in young and older adults. Nutr 32: 1211 – 1216
Gellert S., Schuchardt JP., Hahn A. (2016): Higher omega – 3 index and DHA status in pregnant women compared to lactating woman – results from a German nation – wide cross – sectional study. Prostaglandins Leucot Essent Fatty Acids 109: 22 – 28
Dawczynski C., Lorkowski S. (2015): Prävention kardiovaskulärer Erkrankungen. Cardiovasc 15: 38 – 43
Bryhn M. (2015): Prevention of sports injuries by marine omega – 3 fatty acids . J Am Coll Nutr 34: 60 – 61
Smith GL., Julliand S., Reeds DN., Sinacore DR., Klein S., Mittendorfer B. (2015): Fish oil – derived n – 3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 102: 115 – 122
Lorente – Cebrian S., Costa AG., Navas – Carretero S., Zabala M., Laiglesia LM., Martinez JA., Moreno – Aliaga MJ. (2015): An update on the role of omega – 3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 71: 341 – 349
Padro T., Vilahur G., Sanchez – Hernandez J., Hernandez M., Antonijoan RM., Perez A., Badimon L. (2015): Lipidomic changes of LDL in overweight and moderately hypercholest subjects taking phytosterol – and omega – 3 – supplemented milk. J Lipid Res 56: 1043 – 1056
Ellulu MS., Khaza`ai H., Abed Y., Rahmat A., Ismail P., Ranneh Y. (2015): Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharm 23: 79 – 89
Bibus D., Lands B. ( 2015): Balancing proportions of competing omega – 3 and omega – 6 highly unsaturated fatty acids (HUFA) in tissue lipids. Prostaglandins Leucot Essent Fatty Acids 99: 19 – 23
Lands B. (2015): Omega – 3 PUFAs lower the propensity for arachidonic acid cascade overreaction. BioMed Res Int : article ID 285135: 1 – 8
Skarke C., Alamuddin N., Lawson JA., Li X., Ferguson JF., Reilly MP., Fitz Gerald GA. (2015): Bioactive products formed in humans from fish oils. J Lipid Res 56: 1808 – 1820
Singer P, Schulz-Berlekamp G, Seyf A (2015): “Eskimodiät” – ein Mythos? Ernährung und Medizin 30: 60 – 68
Weylandt KH, Serini S, Chen YQ, Su HM, Lim K,Calviello G (2015): Omega-3 polyunsaturated fatty acids: The way forward in times of mixed evidence. Biomed Res Int: Article ID 143109
Fischer S, Glei M (2015): Health aspects of regular consumption of fish and omega-3-fatty acids. Ernahrungs Umschau 62: 140 – 151
Zebrowska A, Mizia-Stec K, Mizia M, Gasior Z, Poprzecki S (2015): Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance – trained athletes. Eur J Sport Sci 15: 305 – 314
Lewis EJH, Radonic PW, Wolever TMS, Wells GD (2015): 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo. J Int Soc Sports Nutr 12: 2
Fayet-Moore F, Baghurst K, Meyer BJ (2015): Four models including fish, seafood, red meat and enriched foods to achieve Australien Dietary recommendations for n-3 LCPUFA for all life – stages. Nutrients 7: 8602 – 8614
Ellulu MS, Khaza’ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y (2015): Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharmacology 23: 79 – 89
Miyata J, Arita M (2015): Role of omega 3-fatty acids and their metabolites in asthma and allergic diseases. Allergol Int 64: 27 – 34
Skulas-Ray AN, Flock MR, Richter CK, Harris WS, West SG, Kris-Etherton PM (2015): Red blood cell docosapentaenoic acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose – dependently increases following n-3 fatty acid supplementation. Nutrients 7: 6390 – 6404
Lopez-Vicario C, Alcaraz-Quiles J, Garcia-Alonso V, Rius B, Hwang SH, Titos E, Lopategi A, Hammock BC, Arroyo V, Claria J (2015): Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides. PNAS 112: 536 – 541
Elwakeel NM, Hazaa HH (2015): Effect of omega-3 fatty acids plus low – dose aspirin on both clinical and biochemical profiles of patients with chronic peridontitis and type 2 diabetes: a randomized double blind placebo-controlled study. J Peridontal Res 50: 721 – 729
von Schacky C, Kemper M, Haslbauer R, Halle M (2014): Low omega-3 index in 106 german elite winter endurance athletes: A pilot study. Int J Sport Nutr Exercise Metab 24: 559 – 564
Nagvi AZ, Hasturk H, Mu L, Phillips RS, Davis RB, Halem S, Campos H, Goodson JM, Van Dyke TE, Mukamal KJ (2014): Docosahexaenoic acid and peridontitis in adults: A randomized controlled trial. J Dent Res 93: 767 – 773
Molfino A, Gioia G, Fanelli FR, Muscaritoli M (2014): The role for dietary omega-3 fatty acids supplementation in older adults. Nutrients 6: 4058 – 4072
Romanatto T, Fiamoncini J, Wang B, Curi R, Kang JX (2014): Elevated tissue omega-3 fatty acid status prevents age – related glucose intolerance in fat-1 transgenic mice. Biochim Biophys Acta 1842: 186 – 191
Barden A, Mas E, Croft KD, Phillips M, Mori TA (2014): Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res 55: 2401 – 2407
Moosheer SM, Waldschütz W, Itariu BK, Brath H, Stulnig TM (2014): A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes 8: 308 – 314
Howe PRC, Buckley JD, Murphy KJ, Pettman T, Milte C, Coates AM (2014): Relationship between erythrocyte omega-3 content and obesity is gender dependent. Nutrients 6: 1850 – 1860
Macartney MJ, Hingley L, Brown MA, Peoples GE, McLennan PL (2014): Intrinsic heart rate recovery after dynamic exercise is improved with an increased omega-3 index in healthy males. Br J Nutr 112: 1984 – 1992
Papanikolaou Y, Brooks J, Reider C, Fulgoni VL (2014): U.S. adults are not meeting recommended levels for fish and omega-3-fatty acid intake: Results of an analysis using observational data from NHANES 2003 – 2008. Nutr J 13: 31 doi: 10.1186/1475-2891-13-31
Schebb NH, Ostermann AL, Yang J, Hammock BD, Hahn A, Schuchardt JP (2014): Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins. Prostaglandins Other Lipid Mediat 113 – 115: 21 – 29
Schuchardt JP, Schmidt S, Kressel G, Willenberg I, Hammock BD, Hahn A, Schebb NH (2014): Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men. Prostaglandins Leucot Essent Fatty Acids 90: 27 – 37
Lager S, Ramirez V, Gaccioli F, Jansson T, Powell TL (2014): Expression and localization of the omega-3 fatty acid receptor GPR 120 in human term placenta. Placenta 35: 523 – 525
Li J, Li FR, Wei D, Jia W, Kang JX, Stefanovic-Racic M, Dai Y, Zhao AZ (2014): Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice. Mol Endocrinol 28: 1316 – 1328
Singer P, Wirth M, Löhlein I (2014): Fettreiche Seefische in Konserven als Quellen von Omega-3-Fettsäuren. Deklaration, Wirkungen und Bedeutung für die Ernährungspraxis. Ernährung im Fokus 14: 189-197
Richter V, Blüher M, Ceglarek U,Thiery J, Hamm M (2014): Adipositas und Omega-3-Fettsäuren: Die Rolle von Mediatoren der Entzündungsauflösung. Adipositas 8: 25-31
von Schacky C, Kemper M, Haslbauer R, Halle M (2014): Low omega-3 index in 106 german elite winter endurance athletes: a pilot study. Int J Sport Nutr Exerc Metab 24: 559-564
Yates CM, Calder PC, Ed Rainger G (2014): Pharmacology and Therapeutics of omega-3-polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther 141: 272-282
Taha AY, Cheon Y, Faurot KF, Macintosh B, Majchrzak-Hong SF, Mann JD, Hibbeln JR, Ringel A, Ramsden CE (2014): Dietary omega–6–fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools. Prostaglandins Leucot Essent Fatty Acids 90: 151-157
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH (2014): Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP –epoxygenase pathway. J Lipid Res 55: 1150-1164
Koletzko B, Boey CC, Campoy C, Carlson SE, Chang N, Guillermo-Tuazon MA, Joshi S, Prell C, Quak SH, Sjarif DR, Su Y, Supapannachart S, Yamashiro Y, Osendarp SJ (2014): Current information and asian perspectives on long – chain polyunsaturated fatty acids in pregnancy, lactation, and infancy: systematic review and practice recommendations from an early nutrition academy workshop. Ann Nutr Metab 65: 49-80
Standl M, Thiering E, Demmelmair H, Koletzko B, Heinrich J (2014): Age – dependent effects of cord blood long-chain PUFA composition on BMI during the first 10 years of life. Br J Nutr 13: 1-8
Kaur N, Chugh V, Gupta AK (2014): Essential fatty acids as functional components of foods – a review. J Food Sci Technol 51: 2289-2303
Singer P, Wirth M (2013): Zum Gehalt von Omega-3-Fettsäuren in fetten Seefischen und Fischkonserven. Deklaration als Innovation und Bedeutung für die Ernährungspraxis. Dt Lebensmittel-Rundschau 109: 643-651
Spite M (2013): Deciphering the role of n-3 polyunsaturated fatty acid – derived lipid mediators in health and disease. Proc Nutr Soc 2: 1-10
Gray B, Steyn F, Davies PSW, Vitetta L (2013): Omega-3-fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. European Journal of Clinical Nutrition 67: 1234-1242
Superko RH, Superko SM, Nasir K, Agatston A, Garrett BC (2013): Contemporary Reviews in Cardiovascular Medicine: Omega-3 fatty acid blood levels clinical significance and controversy. Circulation 128: 2154-2161
Ogawa S, Abe T, Nako K, Okamura M, Senda M, Sakamoto T, Ito S, and the DIMS study group (2013): Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes. Tohoku J. Exp. Med. 231: 63-74
Koletzko B, Bauer CP, Bung P, Cremer M, Flothkötter M, Hellmers C, Kersting M, Krawinkel M, Przyrembel H, Rasenack R, Schäfer T, Vetter K, Wahn U, Weissenborn A, Wöckel A (2013): German national consensus recommendations on nutrition and lifestyle in pregnancy by the Healthy Start – Young Family Network. Ann Nutr Metab 63: 311-322
Rogers LK, Valentine CJ, Keim SA (2013): DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 70: 13-19
Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, Mc Connell JP (2013): Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88: 257-263
Lattka E, Koletzko B, Zeilinger S, Hibbeln JR, Klopp N, Ring SM, Steer CD (2013): Umbilical cord PUFA are determined by maternal and child fatty acid desaturase (FADS) genetic variants in the Avon Longitudinal Study of Parents and Children (ALSPAC). Br J Nutr 109: 1196-210
Maskrey BH, Megson IL, Rossi AG, Whitfield D (2013): Emerging importance of omega-3 fatty acids in the innate immune response: Molecular mechanisms and lipidomic strategies for their analysis. Mol Nutr Food Res 57: 1390-1400
Schuchardt JP, Hahn A (2013): Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 89: 1-8
Larque E, Gil-Sanchez A, Prieto-Sanchez MT, Koletzko B (2012): Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr 107: 77-84
Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP (2012): Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutr Metab 9: 45
Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP (2012): Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial. Lipid Health Dis 11: 105
Shinohara M, Mirakaj V, Serhan CN (2012): Functional metabolomics reveals novel active products in the DHA metabolome. Frontiers In Immunology 3 article 81: 1-8
Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B (2012): Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolving and protektin formation. Prostaglandins Other Lipid Mediat 97: 73-82
Calder PC (2011): Fatty acids and inflammation: The cutting edge between food and pharma. Eur J Pharmacol 668: 50-58
Faber J, Berkhout M, Vos AP, Sijben JB, Calder PC, Garssen J, van Helvoort A (2011): Supplementation with a fish oil-enriched, high-protein medical food lead to rapid incorporation of PA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr 141: 964-970
Neubronner J, Schuchardt JP, Kressel G, Merkel M, von Schacky C, Hahn A (2011): Enhanced increase of omega-3-index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr 65: 247-254
Richter V, Hamm M, Löhlein I, Bahri D, Kasper H, Klör H-U, Neuberger D, Singer P, Wahrburg U (2011): Langkettige Omega-3-Fettsäuren: Bedeutung und Versorgungskonzept. Dtsch Apoth Ztg 51: 2953-2957
Richter V, Hamm M (2011): Stellenwert der Omega-3-Fettsäuren in unterschiedlichen Lebensperioden. kinderkrankenschwester 30: 207-210
Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A (2011): Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations – a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis 10: 145
Singer P (2011). Omega-3-Fettsäuren als Therapieoption für NAFLD. MMW – Fortschr Med 153: 90-94
Arnold C, Konkel A, Fischer R, Schunck W-H (2010): Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids. Pharmacol Raports 62: 536-547
Singer P (2010): Praktische Aspekte bei der Zufuhr von Omega-3-Fettsäuren. Ernährung und Medizin Suppl S1: 3-18
Bresson J-L, Flynn A, Heinonen M, Hulshof K, Korhonen H, Lagiou P, Lovik M, Marchelli R, Martin A, Moseley B, Przyrembel H, Salminen S, Strain S (JJ), Strobel S, Tetens I, van den Berg H, van Loveren H, Verhagen H (2009): Labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids: Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from the commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA J 1176: 1-11
Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J (2009): Toward establishing dietary reference intake for eicosapentaenoic and docosahexaenoic acids. J Nutr 139: 804-819
Koletzko B, Lien E, Agostoni C, Böhles H, Campoy C, Cetin I, Decsi T, Dudenhausen JW, Dupont C, Forsyth S, Hoesli I, Holzgreve W, Lapillone A, Putet G, Secher NJ, Symonds M, Szajewska H, Willats P, Uauy R (2008): World Association of Perinatal Medicins Dietary Guidelines Working Group: The roles of long chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36: 5-14
Hamm M, Neuberger D (2008): Omega-3 aktiv – Gesundheit aus dem Meer. Hannover: Schlütersche Verlagsgesellschaft mbH & Co KG
Singer P (2008): Geringer Gehalt von Omega-3-Fettsäuren bei Vegetariern und Veganern. Komplement Integr Med 49: 16-23
Richter V, Rassoul F, Hamm M (2007): Jugendliche oft mit Omega-3-Fettsäuren unterversorgt. Dtsch Apoth Ztg 147: 5269-5272
American Heart Association Nutrition Committee (2006): Scientific Statement; Diet and Lifestyle Recommendations Revision 2006. Circulation 114: 82-96
Deckelbaum R J, Worgall TS, Seo T (2006): n-3 Fatty acids and gene expression. Am J Clin Nutr 83 (suppl): 1520-1525
ISSFAL (2004): Recommendations for intake of polyunsaturated fatty acids in healthy adults. mehr Informationen »
mehr Informationen http://www.issfal.org/news-links/resources/publications/PUFAIntakeReccomdFinalReport.pdf
Singer P (2004): Versorgung mit Omega-3-Fettsäuren. Regulierungsmöglichkeiten, Grenzen, Perspektiven. J Orthomol Med 12: 336-349
Beermann C, Jelinek J, Reinecker T, Hauenschild A, Boehm G, Klör H-U (2003): Short time effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis 2: 10
Bahri D, Gusko M, Hamm M, Kasper H, Klör H-U, Neuberger D, Singer P (2002): Bedeutung und empfehlenswerte Höhe der Zufuhr langkettiger Omega-3-Fettsäuren. Ein Konsensus-Statement des Arbeitskreises Omega-3. Ernährungs-Umschau 49: 94-98
Singer P (2000): Was sind, wie wirken Omega-3-Fettsäuren? Frankfurt / Main: Umschau Zeitschriftenverlag Breitenstein GmbH
Simopoulos AP (1991): Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54: 438-463
Singer P (1991): Messung der Omega-3-Fettsäuren im Blutplasma für Bioverfügbarkeits- und Compliance-Untersuchungen. In: Schettler G (Hrsg.): Omega-3-Fettsäuren in Forschung und Praxis. Schattauer Verlag Stuttgart, New York: 1-9
Singer P (1986): Die Rolle der Eicosapentaensäure im Rahmen polyensäurereicher Diäten. Ernährungs-Umschau 33: 218-220

Literatur zu Omega-3-Fettsäuren und Herz-Kreislauf-Erkrankungen

Drenjancevic I., Pitha J. (2022): Omega-3 polyunsaturated fatty acids – vascular and cardiac effects on the cellular and molecular level (Narrative Review). Int J Mol Sci 22:2104
Sherrat S.C.R., Libby P., Bhatt D.L., Mason R.P. (2022): A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular outcomes. Prostaglandins Leukot Essent Fatty Acids 182: 1022450
Liao J., Xiong Q., Yin Y., Ling Z., Chen S. (2022): The effects of fish oil on cardiovascular diseases: Systematical evaluation and recent advance. Front Cardiovasc Med 8:802306
Gaba P., Bhatt D.L., Mason R. P., Miller M., Verma S., Steg G., Boden W.E. (2022): Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT. J Clin Lipidol 16:389-402
Selvaraj S., Bhatt D.L., Steg P.G., Miller M., Brinton E.A., Jacobson T.A., Juliano R.A. et al. (2022): Impact of icosapent ethyl on cardiovascular risk reduction in patients with heart failure in REDUCE-IT. J Am Heart Assoc 11:e024999
Chapman M. J., Zamorano J.L., Parhofer K.G. (2022): Reducing residual cardiovascular risk in Europa: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Pharmacol Ther 237:108127
Miller M., Tokgozoglu L., Parhofer K.G., Handelsman Y., Leiter L.A., Landmesser U., Brinton E.A. (2022): Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements. Expert Rev Cardiovasc Ther 20:609-625
Gaba P., Bhatt D. L., Steg P.G., Miller M., Brinton E. A., Jacobson T. A., Ketchum S. B. (2022): Prevention of cardiovascular events and mortality with icosapent ethyl in patients with prior myocardial infarction. J Am Coll Cardiol 79:1660-1671
Zhang X., Ritonja J. A., Zhou N., Chen B. E., Xinzhi L. (2022): Omega – 3 polyunsaturated fatty acids intake and blood pressure: A dose – response meta – analysis of randomized controlled trials. J Am Heart Assoc 11: e025071
Zhu J., Xun P. C., Kolencik M., Yang K. F., Fly A. D., Kahe K. (2022): Do B vitamins enhance the effect of omega – 3 polyunsaturated fatty acids on cardiovascular diseases ? A systematic review of clinical trials. Nutrients 14: 1608
Alfaddagh A., Kapoor K., Dardari Z. A., Bhatt D. L., Budoff M. J., Nasir K., Miller M. (2022): Omega – 3 fatty acids , subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention. Atherosclerosis 353:11-19
Ruscica M., Sirtori C. R., Carugo S., Calder P. C., Corsini A. (2022): Omega – 3 and cardiovascular prevention – Is this still a choice? Pharmacol Res 182: 106342
Jiang H., Wang L., Wang D., Yan N., Li C., Wu M., Wang F. (2022): Omega – 3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease , cancer, and mortality. Clin Nutr 41: 1798-1807
Yokoyama Y., Kuno T., Morita S. X., Slipczuk L., Takagi H., Briasoulis A., Latib A. (2022): Eicosapentaenoic acid for cardiovascular events reduction – systematic review and network meta – analysis of randomized controlled trials. J Cardiol 80: 416- 422
Xu Q., Du L., Gu H., Ji M., Zhan L. (2022): The effect of omega – 3 polyunsaturated fatty acids on stroke treatment and prevention : a systematic review and meta – analysis. Nutr Hosp 39: 924-935
Maruyama K., Khairunnisa S., Saito I., Tanigawa T., Tomooka K., Minato – Inokawa S., Sano M. (2022): Association of fish and omega – 3 fatty acid intake with carotid intima – media thickness in middle – aged to elderly Japanese men and women : The toon health study. Nutrients 14: 3644 O´Connell T., Murphy K. A., Zhang N., Puccini S. J., Healy C. L., Harsch B. A., Zhang M. J. ( 2022): Signaling through free fatty acid receptor 4 attenuates cardiometabolic disease. Physiologhy ( Bethesda) 37: 311-322
Pisaniello A. D., Psaltis P. J., King P. M., Liu Ge., Gibson R. A., Tan J. T., Duong MN., Nguyen T., Bursill C. A., Worthley M. I., Nicholls S. J., Di Bartolo B. A. (2021): Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects. Atherosclerosis 324: 27-3
Picard F., Steg P.G. (2021): Cardiovascular disease risk reduction in mild-moderate hypertriglyceridemia: Integrating prescription of omega-3 with standard treatment. Curr Atheroscler Rep 23:27.doi:10.1007/s11883-021-00919-2
Mason R. P., Eckel R. H. (2021): Mechanistic insights from REDUCE – IT STRENTHen the case against triglyceride lowering as a strategy for cardiovascular disease risk reduction. Am J Med 134: 1085-1090
Leao M de Castro., Pohlmann A. R., Alves A deCristo. S., Farsky S. H. P., Uchiyama M. K., Araki K., Sandri S., Guterres S. St., Castro I. A. (2021): Docosahexaenoic acid nanoencapsulated with anti- PECAM-1 as co-theraphy for atherosclerosis regression. Eur J Pharm Biopharm 159: 99-107
Welty F. K., Schulte F., Alfaddagh A., Elajami T. K., Bistrian B. R., Hardt M. (2021): Regression of human coronary artery plaque is associated with a high ratio of ( 18-hydroxy-eicosapentaenoic acid+ resolving E1) to leucotriene B 4. FASEB J 35: e21448. doi:10.1096/fj. 202002471R
Nelson J. R., Budoff M., Wani O.R., Le V., Patel D.K., Nelson A., Nemiroff R. L. (2021): EPA`s pleiotropic mechanisms of action: a narrative review. Postgrad Med 133: 651-664
Liu Q. K. (2021): Trglyceride-lowering and anti- inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerosic cardiovascular risk reduction. J Clin Lipidol S1933 -2874(21)00108-2. doi: 10.1016/j.jaci.2021.05.007
Jiang L., Wang J., Xiong K., Xu L., Zhang B., Ma A. (2021): Intake of fish and marine n-3 polyunsaturated fatty acids and risk of cardiovascular disease mortality: A meta- analysis of prospective cohort studies. Nutrients 13: 2342
Goncalinho G. H.F., Sampaio G. R., Soares- Freitas R. A. M., Damasceno N. R. T.(2021): Omega-3 fatty acids in erythrocyte membranes as predictors of lower cardiovascular risk in adults without previous cardiovascular events. Nutrients 13:1919
Pareek M., Mason R. P., Bhatt D. L. (2021): Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides. Expert Opin Drug Saf 1-12 doi:10.1080/14740338.2021.1954158
Barry A .R., Dixon D. L. (2021): Omega-3 fatty acids for the prevention of atherosclerosic cardiovascular disease. Pharmacotherapy doi: 10-1002/phar.2615
Sypniewska G., Kruszewski St. (2021): Cardioprotective effects of nutraceuticals: Focus on omega-3 polyunsaturated fatty acids. Nutrients 13: 3184
Sobrino A., Walker M. E., Colas R.A., Dalli J. (2020):Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro- resolving mediators. PLoS One 15: e0242543 Hosseini Z., Marinello M., Decker C., Sansbury B. E., Sadhu S., Gerlach B. D., Ramos R. B., Adam A. P., Spite M., Fredman G. (2021): Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation. Atherosclerosis, Thrombosis, and Vascular Biology 41:1062-1075
von Schacky, C. (2020): Omega-3 index in 2018/19. Proc Nutr Soc.1-7, doi:10.1017/S0029665120006989
Mason RP., Libby P., Bhatt DL. (2020): Emerging mechanisms of cardiovascular protection for the omega -3 fatty acid eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 40:1135-1147
Innes JK., Calder PC. (2020): Marine omega-3 (N3) fatty acids for cardiovascular health: An update for 2020. Int J Mol Sci. 21: 1362
Ferrari R.,Censi S., Cimaglia P. (2020): The journey of omega-3 fatty acids in cardiovascular medicine. Eur Heart J Suppl.22: J49-J53
Artiach G., Carracedo M., Plunde O., Wheelock CE.,Thul S., Sjövall P., Franko- Cereceda., A., Laguna- Fernandez A., Arnardottir H., Bäck M. (2020): Omega-3 polyunsaturated fatty acids decrease aortic valve disease through the resolvin E1 and chem. R23 axis. Circulation 142:776-789
Arnesen H., Myhre PL., Seljeflot I. (2020): Very long chain marine n-3 polyunsaturated fatty acids in atherothrombotic heart disease. A brief review, with a focus on metabolic effects. Nutrients 12:3014
Shramko VS., Polonskaya YV., Kashtanova EV., Stakhneva E. , Ragino YI. (2020): The short overview on the relevance of fatty acids for human cardiovascular disorders. Biomolecules 10: 1127
Watanabe Y., Tatsuno I. (2019): Prevention of cardiovascular events with omega-3 polyunsaturated fatty acids and the mechanism involved. J Atheroscler Thromb. doi: 10.5551/jat.50658
Kris-Etherton PM., Richter CK., Bowen KJ., Skulas-Ray Ac., Jackson KH., Petersen KS., Harris WS. (2019): Methodist Debakey Cardiovasc J 15 : 171-178
Menegaut L., Jalil A., Thomas C., Masson D. (2019): Macrophage fatty acid mechanism and atherosclerosis: The rise of PUFAs . Atherosclerosis 291:52- 61
Carracedo M., Artiach G., Anardottir H., Bäck M. (2019): The resolution of inflammation through omega -3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Sem Immunpathol 41: 757-766
Bhatt DL., Steg PG., Miller M., Jacobson TA., Ketchum SB., Doyle RT., Juliano RA., Jiao L., Granowitz C., Tardif JC., Ballantyne CM. (2019): Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380: 11-22
Harris WS. (2019): Understanding why REDUCE-IT was positive – mechanistic overview of eicosapentaenoic acid. Prog Cardiovasc Dis 62: 401- 405
Oppedisano F., Macri R., Gliozzi M., Musolino V., Carresi C., Maiuolo J., Bosco F., Nucera S., Zito MC., Guarnieri L., Scarano F., Nicita C., Coppoletta AR., Ruga S., Scicchitano M., Mollace R., Palma E., Mollace V. (2020): The anti-inflammatory and antioxidant properties of n-3 PUFAs : Their role in cardiovascular protection . Biomedicines 8: 306 O` Connell TD., Mason RP., Budoff MJ., Navar AM., Shearer GC. (2020): Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites. Eur Heart Suppl 22:J3-J20
von Schacky C. (2019): Verwirrung um die Wirkung von Omega-3-Fettsäuren. Betrachtung von Studiendaten unter Berücksichtigung des Omega-3-Index. Der Internist http://doi.org/10.1007/s00108-019-00687-x
Berliner D., Mattern S., Wellige M., Malsch C., Güder G., Brenner S., Morbach C., Deubner N., Breunig M., Kiefl R., Angermann CE., Ertl G., von Schacky C., Störk S. (2019): The omega-3 index in patients with heart failure: a prospective cohort study. Prostaglandins Leucot Essent Fatty Acids 140: 34-41
Lechner K., von Schacky C., McKenzie AL., Worm N., Nixdorff U., Lechner B., Kränkel N., Halle M., Krauss RM., Scherr J. (2019): Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol 13: 2047487319869400. doi: 10. 1177/2047487319869400.
Meital LT., Windsor MT., Perissiou M., Schulze K., Magee R., Kuballa A., Golledge J., Bailey TG., Askew CD., Russell FD. (2019): Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm. Sci Rep 10: 12978. doi: 10.1038/s41598-019-49362-z
Sakamoto A., Saotome M., Iguchi K., Maekawa Y. (2019): Marine-derived omega-3 polyunsaturated fatty acids and heart failure: current understanding for basic clinical relevance. Int J Mol Sci 20: 4025 doi:10.3390/ijms20164025
Stupin M., Kibel A.,Stupin A., Selthofer-Relatic K., Matic A., Mihalj M.,Mihaljevic Z.,Jukic I.,Drenjancevic I. (2019): The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology,microvascular function, and physical performance in health and cardiovascular diseases; is there an interaction of exercise and dietary n-3 PUFA intake? Frontiers in Physiology 10: Article 1129
Baghai TC., Varallo-Bedarida G., Born C., Häfner S., Schüle C., Eser D., Zill P., Manook A., Weigl J., Jooyandeh S., Nothdurfter C., von Schacky C., Bondy B., Rupprecht R. (2018): Classical risk factors and inflammatory biomarkers: one of the missing biological links between cardiovascular disease and major depressive disorder. Int J Mol Sci 19: 1740
Ramirez JL., Zahner GJ, Spaulding KA., Khetani SA., Hills NK., Gasper WJ., Harris WS., Cohen BE., Grenon SM. (2019): Peripheral artery disease is associated with a deficiency of erythrocyte membrane n-3 polyunsaturated fatty acids. Lipids 54: 211-219
Nelson JR., Raskin S. (2019): The eicopentaenoic acid: arachdonic acid ratio and its clinical utility in cardiovascular disease. Postgrad Med 131: 268-277
Block RC., Liu L., Herrington DM., Huang S., Tsai MY., O`Connell TD., Shearer GC. (2019): Predicting risk for incident heart failure with omega-3 fatty acids: from MESA. JACC Heart Fail 7: 651-661
Zhuang P., Zhang Y., He W., Chen X., Chen J., He L., Mao L., Wu F., Jiao J. (2019): Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521 120 individuals with 16 years of follow-up. Circ Res 124: 757-768
Simonetto M., Infante M., Sacco RL., Rundeck T., Della-Morte D. (2019): A novel anti-inflammatory role of omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia. Nutrients 11 pii: E2279. doi: 10.3390/nu11102279
Bäck M., Hansson GK. (2019): Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation. FASEB J 33: 1536-1539
Bäck M., Yurdagul A Jr., Tabas I., Öörni K., Kovanen PT. (2019): Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 16: 389-406
Alfaddagh A., Elajami TK., Saleh M., Mohebali D., Bistrian BR., Welty FK. (2019): An omega-3 fatty acid plasma index ≥ 4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment. Atherosclerosis 285: 153-162 Sekikawa A., Mahajan H., Kadowaki S., Hisamatsu T., Miyagawa N., Fujiyoshi A., Kadota A., Maegawa H., Murata K., Miura K., Edmundowicz D., Ueshima H., SESSA Resarch Group. (2019): Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men. Eur J Clin Nutr 73: 783-792
Maki K C., Palacios O M., Bell M., Toth PP. (2017): Use of supplemental long – chain omega – 3 – fatty acids and risk for cardiac death: An updated meta- analysis and review of research gaps. J Clin Lipidiol, dx.doi.org/10.1016/j. jacl.2017.07.010
Langlois PL., Hardy G., Manzanares W. (2017): ω – 3 polyunsaturated fatty acids in cardiac surgery patients. JPEN J Parenter Enteral Nutr 41: 152 – 154
Harris WS., Del Gobbo L., Tintle NL. (2017): The omega – 3 index and relative risk for coronary heart disease mortality: estimation from 10 cohort studies. Atheroscl 262: 51 – 54
Manuelli M., Della Guardia L., Cena H. (2017): Enriching diet with n – 3 PUFAs to help prevent cardiovascular diseases in healthy adults: results from clinical trials. Int J Mol Sci 18: pii E1552
Schaller MS., Zahner GJ., Gasper WJ., Harris WS., Conte MS., Hills NK., Grenon SM. (2017): Relationship between the omega – 3 index and specialized pro – resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. J Clin Lipidol, doi: 10.1016/j.jacl.2017.06.011
Watanabe Y., Tatsuno I. (2017): Omega – 3 polyunsaturated fatty acids for cardiovascular diseases : present, past and future. Expert Rev Clin Pharmacol 10: 865 – 873
Nishizaki Y., Shimada K., Daida H. (2017): The balance of omega – 3 polyunsaturated fatty acids for – reducing residual risks in patients with coronary artery disease. Acta Cardiol 72: 240 – 248
Delgado GE., Krämer BK., Lorkowski S., März W., von Schacky C., Kleber ME. (2017): Individual omega – 9 monounsaturated fatty acids and mortality – the Ludwigshafen risk and cardiovascular health study. J Clin Lipidol 11: 126 – 135
Delgado GE., März W., Lorkowski S., von Schacky C., Kleber ME. (2017): Omega – 6 fatty acids: opposing associations with risk – the Ludwigshafen risk and cardiovascular health study. J Clin Lipidol, doi:10.1016/j.jacl.2017.05.003
Yu Z., Huang T., Zheng Y., Wang T., Heianza Y., Sun D., Campos H.,Qi L. (2017): PCSK9 variant, long – chain n – 3 PUFAs, and risk of nonfatal myocardial infarction in Costa Rican Hispanics. Am J Clin Nutr, doi: 10.3945/ajcn.116.148106
Zehr KR., Walker MK. (2017): Omega -3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A review. Prostaglandins Other Lipid Mediat, doi: 10.1016/j.prostaglandins.2017.07.005
Veenstra J., Kalsbeek A., Westra J., Disselkoen C., Smith C., Tintle N. (2017): Genome- wide interaction study of omega – 3 PUFAs and other fatty acids on inflammatory biomarkers of cardiovascular health in the Framingham Heart Study. Nutrients 9: pii E900
Mendez L., Dasilva G., Taltavull N., Romeu M., Medina I. (2017): Marine lipids on cardiovascular diseases and other chronic diseases induced by diet: an insight provided by proteomics and lipidomics. Mar Drugs 15: pii E258
Chan DC., Pang J., Barrett PH., Sullivan Dr., Mori TA., Burnett JR., van Bockxmeer FM., Watts GF. (2016): Effect of omega – 3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy. Nutr Metab Cardiovasc 26: 1140 – 1145
Elajami TK., Colas RA., Dalli J., Chiang N., Serhan CN., Welty FK. (2016): Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J 30: 2792 – 2801
Kleber ME., Delgado GE., Lorkowski S., März W., von Schacky C. (2016): Omega – 3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen risk and cardiovascular health study. Atherosclerosis 252: 175 – 181
Kleber ME., Delgado GE., Lorkowski S., März W., von Schacky C. (2016): Data on gender and subgroup specific analyses of omega – 3 fatty acids in the Ludwigshafen risk and cardiovascular health study. Data Brief 8: 1311 – 1321
Rice HB., Bernasconi A., Maki KC., Harris WS.,von Schacky C., Calder PC. (2016): Conducting omega – 3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014. Prostaglandins, Leukot Essent Fatty Acids 107: 30 – 42
Walz CP., Barry AR., Koshman SL. (2016): Omega – 3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease. Can Pharm J (Ott) 149:166 – 173
Zock PL., Blom WAM., Nettleton JA., Hornstra G. (2016): Progressing insights into the role of dietary fats in the prevention of cardiovascular disease. Curr Cardiol Rep18: 111 – 124
Bowen KJ., Harris WS., Kris – Etherton PM. (2016): Omega – 3 fatty acids and cardiovascular disease: Are there benefits? Curr Treat Options Cardiovasc Med 18: 69
Chaudhary R., Saadin K., Bliden KP., Harris WS., Dinh B., Sharma T., Tantry US., Gurbel PA. (2016): Risk factors associated with plasma omega – 3 fatty acid levels in patients with suspected coronary artery disease. Prostaglandins, Leukot Essent Fatty Acids 113: 40 – 45
Singh S., Arora RR., Singh M., Khosla S. (2016): Eicosapentaenoic acid versus docosahexaenoic acid as options for vascular risk prevention: A fish story. Am J Ther 23: 905 – 910
Asztalos IB., Gleason JA., Sever S., Gedik R., Asztalos BE., Horvath KV., Dansinger ML., Lamon – Fava S., Schaefer EJ. (2016): Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial. Metabolism 65: 1636 – 1645
Harris WS. (2016): RBC omega – 3 predicts risk for death. Atherosclerosis 252: 192 – 193
Umemoto N., Ishii H., Kamoi D., Aoyama T., Sakakibara T., Takahashi H., Tanaka A., Yasuda Y., Suzuki S., Matsubara T., Murohara T. (2016): Reverse association of omega – 3 / omega – 6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysis. Atherosclerosis 249: 65 – 69
Sansbury BE., Spite M. (2016): Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circ Res 119: 113 – 130
Fialkow J. (2016): Omega – 3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products. Am J Cardiovasc Drugs 16: 229 – 239
Gammelmark A., Nielsen MS., Bork CS., Lundbye – Christensen S., Tionneland A., Overvad K., Schmidt EB. (2016): Adipose tissue content of marine n – 3 polyunsaturated fatty acids ls inversely associated with myocardial infarction. J Am Coll Cardiol 67: 1008 – 1009
Reiner MF., Stivala S., Limacher A., Bonetti NR., Mean M., Egloff M., Rodondi N., Aujeski D., von Schacky C., Lüscher TF., Camici GG., Beer JH. (2016): Omega – 3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. J Thromb Haemost doi: 10. 1111/ jth. 13553
von Schacky C (2015): Omega -3 fatty acids in cardiovascular disease – an uphill battle. Prostaglandins Leucot Essent Fatty Acids 92: 41 – 47
Franzese CJ, Bliden KP, Gesheff MG, Pandya S, Guyer KE, Singla A, Tantry US, Toth PP, Gurbel PA (2015): Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. Am J Cardiol 115: 1204 – 1211
Tani S, Takahashi A, Nagao K, Hirayama A (2015): Association of fish consumption – derived ratio of serum n-3 to n-6 polyunsaturated fatty acids and cardiovascular risk with the prevalence of coronary artery disease. 56: 260 – 268
Maehre HK, Jensen IJ, Elvevoll EO, Eilertsen KE (2015): ω-3 fatty acids and cardiovascular diseases: Effects, mechanisms and dietary relevance. Int J Mol Sci 16: 22631 – 22661
Mori TA (2014): Omega-3 fatty acids and cardiovascular disease: Epidemiology and effects on cardiometabolic risk factors. Food Funct 5: 2004 – 2019
Gilbert K, Bernier J, Godbout R, Rousseau G (2014): Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. Mar Drugs 12: 5396 – 5407
Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, Arita M (2014): 18 HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 211: 1673 – 1687
von Schacky C (2014): Omega-3 fatty acids in cardiovascular disease – An uphill battle. Prostaglandins Leukot Essent Fatty Acids. doi. 10.1016/j.plefa2014.05.004.
von Schacky C (2014): Omega-3 index and cardiovascular health. Nutr 6: 799-814
Merino J, Sala-Vila A, Kones R, Ferre R, Plana N, Girona J, Ibarretxe D, Heras M, Ros E, Masana L (2014): Increasing long-chain n-3 PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk. J Nutr Biochem 25: 642-646
Pacifico L, Giansanti S, Gallozzi A, Chiesa C (2014): Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. Mini Rev Med Chem 14: 791-804
DiNicolantonio JJ, Niazi AK, McCarty ME, O`Keefe JH, Meier P, Lavie CJ (2014): Omega-3s and cardiovascular health. Ochsner J 14: 399-412
Mori TA (2014): Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors. Food Funct 5: 2004-2019
Le Goff W (2014): A new piece in the puzzling effect of n-3 fatty acids on atherosclerosis? Atherosclerosis 235: 358-362
Augustine AH, Lowenstein LM, Harris WS, Shearer GC, Block RC (2014): Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance. Prostaglandins Leucot Essent Fatty Acids 90: 69-75
Kromhout D, de Goede J (2013): Update on cardiometabolic health effects of ω- 3 fatty acids. Curr Opin Lipidol 25: 85-90
Casula M, Soranna D, Catapano AL, Corrao G (2013): Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double-blind, placebo controlled trials. Atheroscler Suppl 14: 243-251
Chang CL, Deckelbaum RJ (2013): Omega-3 fatty acids: mechanisms underlying protective effects in atherosclerosis. Curr Opin Lipidol 24: 345-350
Calder PC (2012): The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 56:1073-1080
Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ (2012): Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 225: 425-431
Richter V, Hamm M (2012): Omega-3-Fettsäuren und Resolvine: Implikationen für die Atheroskleroseprävention. Perfusion 25: 144-152
Singer P, Löhlein I (2012): Erhöhung von LDL-Cholesterin durch Omega-3-Fettsäuren – kein Hinweis auf KHK-Risiko. Ernährung und Medizin 27: 67-72
von Schacky C (2012): Omega-3 Fettsäuren – HS-Omega-3 Index und Gesundheit von Herz und Hirn. Vitalstoffe 2/4: 28-36
Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Rupprecht R, Bondy B, von Schacky C (2011): Major depressive disorder is associated with cardiovascular risk factors and low omega-3 index. J Clin Psychiatry 72: 1242-1247
von Schacky C (2011): The Omega-3 Index as a risk factor for cardiovascular diseases. Prostaglandins Other Lipid Mediat 96: 94-98
Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH (2010): Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of (omega)-3 fatty acids. J Bio Chem 285: 32720-32733
Köhler A, Bittner D, Löw A, von Schacky C (2010): Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 104: 729-736
von Schacky C (2010): Omega-3 index and sudden cardiac death. Nutrients 2: 375-388
von Schacky C (2010): Omega-3 fatty acids vs. cardiac disease – the contribution of the omega-3 index. Cell Mol Biol (Noisy-le-grand) 55: 93-101
von Schacky C (2010):Omega-3 fatty acids and cardiovascular diseases. UNI-MED Verlag AG, Bremen
von Schacky C (2009): Cardiovascular disease prevention and treatment. Prostaglandins Leukot Essent Fatty Acids 81: 193-198
Richter V, Rassoul F, Hamm M (2008): Omega-3-Fettsäuren und kardiovaskuläres Risiko: Konsens trotz weiteren Forschungsbedarfs. Perfusion 21: 50-55
Biscione F, Pignalberi C, Totteri A, Messina F, Altamura G (2007): Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol 5: 163-172
Harris WS, Poston WC, Haddock CK (2007): Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193: 1-10
Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G (2007): Efficacy of n-3 polyunsaturated fatty acids: insights from the GISSI-Prevenzione trial. J Cardiovasc Med 8 (Suppl 1): 34-37
von Schacky C (2007): Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10: 129-135
von Schacky C, Harris WS (2007): Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73: 310-315
von Schacky C, Harris WS (2007): Cardiovascular risk and the omega-3 index. J Cardiovasc Med 8: 46-49
von Schacky C (2006): A review of omega-3 ethyl esters for the cardiovascular prevention and treatment of increased blood triglyceride levels. Vascular Health and Risk Management 2: 251-262
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J (2006): n-3 fatty acids from fish or fish oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary – and secondary – prevention studies: a systematic review. Am. J Clin Nutr 84: 5-17
Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willet WC, Siscovick DS, Rimm EB (2005): Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111: 157-164
Carrero JJ, Baró L, Fonollá J, Gonzáles-Santiago M, Martínez-Férez A, Castillo R, Jiménez J, Boza JJ, López-Huertas E (2004): Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition 20: 521-527
Singer P (2004): Omega-3-Fettsäuren in der KHK-Prävention. Dtsch Apoth Ztg 144: 5509-5513
Singer P, Wirth M (2004): Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial. Prostaglandins Leukot Essent Fatty Acids 71: 153-159
Singer P, Wirth M (2003): Fischöl vermindert Herzrhythmusstörungen – Bedeutung für die Reduktion von Reinfarkten und plötzlichem Herztod. Med Welt 54: 1-8
Singer P (2002): Fluvastatin und Fischöl wirken stärker auf kardiovaskuläre Risikofaktoren als Fluvastatin allein. Med Welt 9: 298-302
Yamada T, Strong JP, Ishii T, Ueno T, Koyama M, Wagayama H, Shimizu A, Sakai T, Malcom GT, Guzman MA (2000): Atherosclerosis and n-3 fatty acids in the population of a fishing village and a farming village in Japan. Atherosclerosis 153: 469-481
Weber PC (1989): Epidemiologische und biochemische Studien über n 3 Fettsäuren in der Prävention der Atherosklerose. Internist 30: 283-290
Singer P, Berger J, Lück K, Taube Ch, Naumann E, Gödicke W (1986): Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 62: 259-265
Kromhout D, Bosschieter EB, de Lezenne Coulander C (1985): The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205-1209
Von Schacky C, Weber PC (1985): Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 76: 2446-2450
Dyerberg J, Bang HO (1982): A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest 42: 7-13
Harris WS, Connor WE, Mc Murry MP (1980): Reduction of plasma lipids and lipoproteins by dietary w-3 fatty acids. Am J Clin Nutr 33: 928-935
Dyerberg J, Bang HO (1979): Lipid metabolism atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis 8: 227-233

Omega-3-Fettsäuren und Gehirnfunktion

Sala – Vila A., Satizabal C. L., Tintle N., Van Lent D. M., Vasan R., Beiser A. S., Seshadri S. (2022): Red blood cell DHA is inversely associated with risk of incident Alzheimer´s disease and all – cause dementia: Framingham offspring study. Nutrients 14: 2408
Hachem M., Nacir H. (2022): Emerging role of phospholipids and lysophospholipids for improving brian docosahexaenoic acid as potential preventive and therapeutic strategies for neurological disease. Int J Mol Sci 23: 3969
Mora I., Arola L., Caimari A., Escote X., Puiggros F. (2022): Structured long – chain omega – 3 fatty acids for improvement of cognitive function during aging. Int J Mol Sci 23: 3472
Zhou L., Xiong J.-Y., Chai Y-Q., Huang L., Tang Z.-Y., Zhang X.-F., Liu B. (2022): Possible antidepressant mechanisms of omega – 3 polyunsaturated fatty acids acting on the central nervous system. Front Psychatry 13: 933704
Rouch L., Giudici K. V., Cantet C., Guyonnet S., Delrieu J., Legrand P., Catheline D. (2022): Associations of erythrocyte omega – 3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer`s disease neuroimaging initiative: Cross – sectional and longitudinal retrospective analyses. Am J Clin Nutr 236: doi 101093
Satizbal C. L., Himali J. J., Beiser A. S., Ramachandran V., Van Lent D. M., Himali D., Aparicio H. J. (2022): Association of blood cell omega – 3 fatty acids with MRI markers and cognitive function in midlife: The framingham heart study. Neurology 10:1212
Tokuda H., Horikawa C., Nishita Y., Nakamura A., Kato T., Kaneda Y., Obata H. (2022): The association between long – chain polyunsaturated fatty acid intake and changes in brain volumes among older communuity – dwelling Japanese people. Neurobiol Aging 117:179-188
Kim H.-Y., Huang B. X., Spector A. A. (2022): Molecular and signaling mechanisms for docosahexaenoic acid – derived neurodevelopment and neuroprotection. Int J Mol Sci 23:4635
Petermann A. B., Reyna-Jeides M., Ortega L., Coddou C., Yevenes G. E. (2022): Roles oft he unsaturated fatty acid dosahexaenoic acid in the central nervous system: Molecular and cellular insights. Int J Mol Sci 23: 5390
Liu J., Sahin C., Ahmad S., Magomedova L., Zhang M., Jia Z., Metherel A. H. (2022): The omega – 3 hydroxy fatty acid 7 ( S) – HDHA is a high- affinity PPARα ligand that regulates brain neuronal morphology. Sci Signal 15:1857
Sala-Vila A., Satizabal C. L., Tintle N., Van Lent D. M., Vasan R. S., Beiser A. S., Seshadri S. ( 2022): Red blood cell DHA is inversely associated with risk of incident Alzheimer`s disease and all- cause dementia: Framingham offspring study. Nutrients 14:2408 Tung T-H., Nguyen N. T. K., Huang S-Y. (2021): New insights into depressive disorder with respect to low-grade inflammation and fish oil intake. J Oleo Sci 70:1539-1550
von Schacky C. (2021): Importance of EPA and DHA blood levels in brain structure and function. Nutrients 13:1074
Esselun C., Dilberger B., Silaidos C.V., Koch E., Schebb N.H., Eckert G.P. (2021): A walnut diet in combination with enriched environment improves cognitive function and affects lipid metabolites in brain and liver of aged NMRI mice. Neuromolecular Medicine 23:140-160
Barnes S., Chowdhury S., Gatto N.M., Fraser G.E., Lee G.J. (2021): Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population. Brain Behav 11:e2273
van Lent D.M., Egert S., Wolfsgruber S., Kleineidam L., Weinhold L., Wagner-Thelen H., Maier W., Jessen F., Ramirez F., Schmid M., Scherer M., Riedel-Heller S.G., Wagner,M. (2021): Eicosapentaenoic acid is associated with decreased incidence of Alzheimer’s demenzia in the oldest old. Nutrients 13:461
Sikka P., Behi T., Sharma S., Sehgal A., Bhatia S., Al-Harrasi A., Singh S., Sharma N., Aleya L. (2021): Exploring the therapeutic potential of omega-3 fatty acids in depression. Environ Sci Pollut Res Int 28:43021-43034
Paduchova Z., Katrencikova B., Vavakova M., Laubertova L., Nagyova Z., Durackova Z., Trebaticka J. (2021): The effect of omega-3 fatty acids on thromboxane, brain-derived neurotropic factor, homocysteine, and vitamin D in depressive children and adolescents: Randomized controlled trial. Nutrients 13:1095
Metherei A.H., Rezaei K., Lacombe R.J.S., Bazinet R.P. (2021): Plasma unesterified eicosapentaenoic acid is converted to docosahexaenoic acid (DHA) in the liver and supplies the brain with DHA in the presence or absence of dietary DHA. Biochim Biophys ActaMol Cell Biol Lipids 1866:158942
Patch C.S., Hill-Yardin E.L., Lewis M, Ryan L., Daly E., Pearce A. J. (2021): The more,the better: High-dose omega-3 fatty acids improve behavioural and molecular outcomes in preclinical models in mild brain injury. Curr Neurol Neurosci Rep 21:45
Chang J. P-C. (2021): Personalised medicine in child and adolescent psychiatry: Focus on omega-3 fatty acids and ADHD. Brain Behav Immun Health 16:100310
Veselinovic A., Petrovic S., Zikic V., Subotic M., Jakowljevic V., Jeremic N., Vucic V. (2021): Neuroinflammation in autism and supplementation based on omega-3 polyunsaturated fatty acids: A narrative review. Medicina (Kaunas) 57:893
Patan M.J., Kennedy D. O., Husberg C., Hustvedt S. A., Calder P. C., Khan J., Forster J., Jackson P. A. (2021): Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials. Am J Clin Nutr 114:914-924
Basak S., Mallic R., Banerjee A., Pathak S., Duttaroy A.K. (2021): Maternal supply of both arachidonic and docosahexaenoic acids is required for optimal neurodevelopment. Nutrients 13:2061 Charriere K., Ghzaiel I., Lizard G., Vejux A. (2021): Involvement of microglia in neurodegenerative diseases: Beneficial effects of docosahexaenoic acid (DHA) supplied by food or combined with nanoparticles. Int J Mol Sci 22:10639
Giacobbe J., Benoiton B., Zunszain P.,Pariante Cm., Borsini A.(2020): The anti-inflammatory role of omega-3 polyunsaturated fatty acids metabolites in pre- clinical models of psychiatric, neurodegenerative, and neurological disorders. Front Psychatry11:122
Joffre C., Dinel AL., Chataigner M., Pallet V., Laye S. (2020): n-3 polyunsaturated fatty acids and their derivates reduce neuroinflammation during aging. Nutrients12: 647
Kokubun K., Nemoto K., Yamakawa Y. (2020): Fish intake may affect brain structure and improve cognitive ability in healthy people. Front Aging Neuroscience 12:76
Ciesielski TH., Williams SM. (2020): Low omega-3 intake is associated with high rates of depression and preterm birth on the country level. Scientific Reports, nature research 10: 19749
Liu ZH., Chen NY., Tu P., Wu CT., Chiu SC., Huang YC., Lim SN., Yip PK. (2020): DHA attenuates cerebral edema following traumatic brain injury via the reduction in blood-brain barrier permeability. Int J Mol Sci 21: 6291
Hsu MC., Huang YS., Ouyang WC. (2020): Beneficial effects of omega-3 fatty acid supplementation in schizophrenia possible mechanisms. Lipids in Health and Disease 19: 159
Pifferi F., Cunnane SC., Guesnet P. ( 2020): Evidence of the role of omega-3 polyunsaturated fatty acids in brain glucose metabolism. Nutrients 12: 1382
van der Wurff ISM., Meyer BJ., de Groot RHM. (2020): Effect of omega-3 long chain polyunsaturated fatty acids ( n-3 LCPUFA) supplementation on cognition in children and adolescents: A systematic literature review with a focus on n-3 LCPUFA blood values and dose of DHA and EPA. Nutrients 12: 3115
Bozzatello P., De Rosa ML., Rocca P., Bellino S. (2020): Effects of omega 3 fatty acids on main dimensions of psychpathology. Int J Mol Sci 21: 6042
DiNicolantonio JJ., O`Keefe JH. (2020): The importance of marine omega-3s for brain development and the prevention and treatment of behavior , mood, and other brain disorders. Nutrients 12:2333 Park SJ., Lee DK., Kim B., Na KS ., Lee CH., Son YD., Lee HJ. (2020): The association between omega-3 fatty acid intake and human brain connectivity in middle-aged depressed women. Nutrients 12:2191
Avallone R., Vitale G., Bertolotti M. (2019): Omega-3 fatty acids and neurodegenerative diseases: new evidence in clinical trials. Int J Mol Sci 20 pii: E4256. doi: 10.3390/ijms20174256
Guu TW.,Mischoulon D., Sarris J., Hibbeln J., McNamara RK., Hamazaki K., Freeman MP., Maes M., Matsuoka YJ., Belmaker RH., Jacka F., Pariante C., Berk M., Marx W., Su KP. (2019): International society for nutritional psychatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychother Psychosom 3: 1-11 doi: 10.1159/000502652
van der Wurff ISM., von Schacky C., Bergeland T., Leontjevas R., Zeegers MP., Jolles J., Kirschner PA., de Groot RHM. (2019): Effect of 1 year krill oil supplementation on cognitive achievement of Dutch adolescents: a double-blind randomized controlled trial. Nutrients 11:1230 doi:10.3390/nu11061230
Yam KY., Schipper L., Reemst K., Ruigrok SR., Abbink MR., Hoeijmakers L., Naninck EFG., Zarekiani P., Oosting A., Van der Beek EM., Lucassen PJ., Korosi A. (2019): Increasing availability of ω-3 fatty acid in the early-life diet prevents the early-life stress-induced cognitive impairments without affecting metabolic alterations. FASEB J 33: 5729-5740
Jerneren F., Cederholm T., Refsum H., Smith AD., Turner C., Palmblad J., Eriksdotter M., Hjorth E., Faxen-Irving G., Wahlund LO., Schultzberg M., Basun H., Freund-Levy Y. (2019): Homocysteine status modifies the treatment effect of omega 3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer`s disease: the OmegAD study. J Alzheimers Dis 69: 189-197
Gonder U., von Schacky C., Worm N., Lechner B., Bock M., Lechner K. (2019): [Dementia and metabolic-vascular risk factors: strategies for prevention]. Dtsch Med Wochenschr 144: 1212-1217
Demmelmair H.,Oyen J., Pickert T., Rauh-Pfeiffer A., Stormark KM., Graff IE., Lie O., Kjellevold M., Koletzko B. (2019): The effect of atlantic salmon consumption on the cognitive performance of preschool children – a randomized controlled trial. Clin Nutr 38: 2558-2568
Morgese MG., Schiavone S., Mhillaj E., Bove M., Tucci P., Trabace L. (2018): N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype. Pharmacol Res 129: 526-534 Pontifex M., Vauzour D., Minihane AM. (2018): The effect of APOE genotype on Alzheimer`s disease risk is influenced by sex and docosahexaenoic acid status. Neurobiol Aging 69: 209-22
Ostermann AI., Reutzel M., Hartung N., Franke N., Kutzner L.,Schoenfeld K., Weylandt K–H., Eckert GP., Schebb NH. (2017): A diet rich in omega – 3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain. Prostaglandins and Other Lipid Mediators, dx.doi.org/10.1016/j.prostaglandins.2017.06.001
Echeverria F., Valenzuela R., Hernandez – Rodas CM., Valenzuela A. (2017): Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: new dietary sources. Prostaglandins Leukot Essent Fatty Acids 124: 1 – 10
Zamroziewicz MK., Paul EJ., Zwilling CE., Barbey AK. (2017): Predictors of memory in healthy aging: polyunsaturated fatty acid balance and fornix white matter integrity. Aging Dis 8: 372 – 383
Nock TG., Chouinard – Watkins R., Plourde M. (2017): Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega – 3 fatty acids and cognitive decline. Biochim Biophys Acta 1862:1068 – 1078
Fraga VG., Carvalho MDG., Caramelli P., De Sousa LP., Gomes KB. (2017): Resolution of inflammation, n – 3 fatty acid supplementation and Alzheimer disease: a narrative review. J Neuroimmunol 310: 111 – 119
Satogami K., Takahashi S., Yamada S., Ukai S., Shinosaki K. (2017): Omega – 3 fatty acids related to cognitive impairment in patients with schizophrenia. Schizophr Res Cogn 9: 8 – 12
Cederholm T. (2017): Fish consumption and omega – 3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer`s disease in older adults – any news? Curr Opin Nutr Metab Care 20: 104 – 109
Amen DG., Harris WS., Kidd PM., Meysami S., Raji CA. (2017): Quantitative erythrocyte omega – 3 EPA plus DHA levels are related to higher regional cerebral blood flow on brain spect. J Alzheimers Dis 58: 1189 – 1199
Ammann EM., Pottala JV., Robinson JG., Espeland MA., Harris WS. (2017): Erythrocyte omega – 3 fatty acids are inversely associated with incident dementia: secondary analyses of longitudinal data from the women`s health initiative memory study (WHIMS). Prostaglandins Leukot Essent Fatty Acids 121: 68 – 75
Zamroziewicz MK., Paul EJ., Zwilling CE., Barbey AK. (2017): Predictors of memory in healthy aging: polyunsaturated fatty acid balance and fornix white matter integrity. Aging Dis 8: 372 – 383
Zamroziewicz MK., Paul EJ., Zwilling CE., Barbey AK. (2017): Determinants of fluid intelligence in healthy aging: omega – 3 polyunsaturated fatty acid status and frontoparietal cortex structure. Nutr Neurosci 11:1 – 10
Schuchardt JP., Köbe T., Witte V., Willers J., Gingrich A., Tesky V., Pantel J., Rujescu D., Illig T.,Flöel A., Hahn A. (2016): Genetic variants of the FADS gene cluster are associated with erythrocyte membrane LC PUFA levels in patients with mild cognitive impairment. J Nutr Health Aging 20: 611 – 620
Berressem D., Koch K., Franke N., Klein J., Eckert GP. (2016): Intravenous treatment with a long-chain omega – 3 lipid emulsion provides neuroprotection in a murine model of ischemic stroke. A pilot study. PLOS ONE, doi:10.1371/journal.pone.0167329
Külzow N., Witte AV., Kerti L., Grittner U., Schuchardt JP., Hahn A., Flöel A. (2016): Impact of omega – 3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimer Dis 51: 713 – 725
Cardoso C., Afonso C., Bandarra NM. (2016): Dietary DHA and health: cognitive function ageing. Nutr Res Rev 29: 281 – 294
Köbe T., Witte AV., Schnelle A., Lesemann A., Fabian S., Tesky VA., Pantel J., Flöel A. (2016): Combined omega – 3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage 131: 226 – 238
Lukaschek K., von Schacky C., Kruse J., Ladwig KH. (2016): Cognitive impairment Is associated with a low omega – 3 index in the elderly: results from the KORA – Age Study. Dement Geriatr Cogn Disord 42: 236 – 245
Devassy JG., Leng S., Gabbs M., Monirujjaman M., Aukema HM. (2016): Omega – 3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease. Adv Nutr 7: 905 – 916
Husted KS., Bouzinova EV. (2016): The importance of n – 6 / n – 3 fatty acids ratio in the major depressive disorder. Medicina (Kaunas) 52: 139 – 147
D`Ascoli TA., Mursu J., Voutilainen S., Kauhanen J., Tuomainen TP., Virtanen JK. (2016): Association between serum long – chain omega – 3 polyunsaturated fatty acids and cognitive performance in elderly men and women: The Kuopio Ischaemic Heart Disease Risk Factor Study. Eur J Clin Nutr 70: 970 – 975
Wysoczanski T., Sokola – Wysoczanska E., Pekala J., Lochynski S., Czyz K., Bodkowski R., Herbinger G., Patkowska – Sokola B., Librowski T. (2016): Omega – 3 fatty acids and their role in central nervous system – a review. Curr Med Chem 23: 816 – 831
McNamara RK., Jandacek R., Tso P., Blom TJ., Welge JA., Strawn JR., Adler CM., Strakowski SM., DelBello MP. (2016): Adolescents with or at ultra – high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodomal risk biomarker. Early Interv Psychiatry 10: 203 – 211
Mc Namara RK. (2016): Role of omega – 3 fatty acids in the Etiology, treatment , and prevention of depression: current status and future directions. J Nutr Intermed Metab 5: 96 – 106
van der Wurff LS., von Schacky C., Berge K., Zeegers MP., Kirschner PA., de Groot RH. (2016): Association between blood omega – 3 index and cognition in typically developing dutch adolescents. Nutr 8: doi: 10.3390/nu8010013
Wang X., Hjorth E., Vedin I., Eriksdotter M., Freund – Levi Y., Wahlund L – O., Cederholm T., Palmblad J., Schultzberg M. (2015): Effects of n – 3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the Omeg AD study. J Lipid Res 56: 674 – 681
Voggt A., Berger M., Obermeier M., Löw A., Seemueller F., Riedel M., Moeller HJ., Zimmermann R., Kirchberg F., von Schacky C., Severus E. (2015): Heart rate variability and omega – 3 index in euthymic patients with bipolar disorders. Eur Psychiatry 30: 228 – 232
Smollich M (2015): Omega-3 fatty acids and brain function. Ernahrungs Umschau 62: 170 – 177
Steenweg-de Graaff JC, Tiemeier H, Basten MG, Rijlaarsdam J, Demmelmair H, Koletzko B, Hofman A, Jaddoe VW, Verhulst FC, Roza SJ (2015): Maternal LC-PUFA status during pregnancy and child problem behaviour: The Generation R Study. Pediatr Res 77: 489 – 497
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE (2015): ω-3 supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J 29: 2681 – 2689
Fiala M, Terrando N, Dalli J (2015): Specialized pro-resolving mediators from omega-3 fatty acids improve amyloid-β phagocytosis and regulate inflammation in patients with minor cognitive impairment. J Alzheimers Dis 48: 293 – 301
Bos DJ, Oranje B, Veerhoek ES, Van Diepen RM, Weusten JM, Demmelmair H, Koletzko B, De Sain-van der Velden MG, Eilander A, Hoeksma M, Durston S (2015):Reduced symptoms of inattention after dietary omega-3 fatty acids supplementation in boys with and without attention deficit/hyperactivity disorder. Neuropsychopharmacology 40: 2298 – 2306
Jerneren F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD (2015): Brain atrophy in cognitively impaired elderly: The importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr 102: 215 – 221
Delpech JC, Madore C, Joffre C, Aubert A, Kang JX, Nadjar A, Laye S (2015): Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation. Neuropsychopharmacology 40: 525 – 536
Baierle M, Vencato PH, Oldenburg L, Bordignon S, Zibetti M, Trentini CM, Duarte M MMF,Veit JC, Somacal S, Emanuelli T, Grune T, Breusing N, Garcia SC (2014): Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly. Nutrients 6: 3624 – 3640
Gow RV, Hibbeln JR (2014): Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child Adolesc Psychiatr Clin N Am 23: 555 – 590
Otsuka R, Tange C, Nishita Y, Kato Y, Imai T, Ando F, Shimokata H (2014): Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese. Eur J Clin Nutr 68: 503 – 509
Brenna JT, Carlson SE (2014): Docosahexaenoic acid and human brain development: Evidence that a dietary supply is needed for optimal development. J Hum Evol 77: 99 – 106
Afshordel S, Hagl S, Werner D, Röhner N, Kögel D, Bazan NG, Eckert GP (2014): Omega-3 polyunsaturated fatty acids improve mitochondrial dysfunction in brain aging – impact of Bcl-2 and NPD-1 like metabolites. Prostaglandins Leukot Essent Fatty Acids 91: doi:10.1016 / j.plefa. 2014.05.008
Widenhom-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H (2014): Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behaviour and cognition in children with attention deficit / hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids 91: 49-60
Cutuli D, De Bartolo P, Caporali P, Laricchiuta D, Foti F, Ronci M, Rossi C, Neri C, Spaletta G, Caltagirone C, Farioli-Vecchioli S, Petrosini L (2014): n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front Aging Neurosci 6: 220
Hennebelle M, Plourde M, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P, Cunnane SC (2014): Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline. Proc Nutr Soc 73: 80-86
Janssen C, Kiliaan AJ (2014): Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 53: 1-17
O`Callaghan N, Parletta N, Milte CM, Benassi-Evans B, Fenech M, Howe PR (2014): Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study. Nutr 30: 489-491
Bowman GL, Dodge HH, Mattek N, Barbey AK, Silbert LC, Shinto L, Howieson DB, Kaye JA, Quinn JE (2013): Plasma omega-3 PUFA and white matter mediated executive decline in older adults. Front Aging Neurosci 5: 92
Firlag M, Kamaszewski M, Gaca K, Adamek D, Balasinska B (2013): The neuroprotective effect of long-term n-3 polyunsaturated fatty acids supplementation in the cerebral cortex and hippocampus of aging rats. Folia Neuropathol 51: 235-242
Orr SK, Palumbo S, Bosetti F, Mount HT, Kang JX, Greenwood CE, Ma DWL, Serhan CN, Bazinet RP (2013): Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem 127: 378-393
Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. (2013): The relationship of docosahexaenoic acid (DHA) with learning and behaviour in healthy children: a review. Nutrients 19: 2777-2810
Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P (2013): Docosahexaenoic acid homeostasis, brain aging and Alzheimer`s disease: Can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids 88: 61-70
Eckert GP, Lipka U, Muller WE (2013): Omega-3 fatty acids in neurodegenerative disease: focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids 88: 105-114
Kang JX, Gleason ED (2013): Omega-3 fatty acids and hippocampal neurogenesis in depression. CNS Neurol Disord Drug Targets 12: 460-465
Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. (2013): The relationship of docosahexaenoic acid (DHA) with learning and behaviour in healthy children: a review. Nutrients 5: 2777-2810
Loef M, Walach H (2013): The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. J Nutr Gerontol Geriatr 32: 1-23
Luchtman DW, Song C (2013): Cognitive enhancement by omega-3 fatty acids from childhood to old age: findings from animal and clinical studies. Neuropharmacology 64: 550-565
Parletta N, Cooper P, Gent DN, Petkov J, O`Dea K (2013): Effects of fish oil supplementation on learning and behaviour of children from Australian indigenous remote community schools: A randomized controlled trial. Prostaglandins Leukot Essent Fatty Acids 89: 71-79
Pu H, Guo Y, Zhang W, Huang L, Wang G, Liou AK, Zhang J, Zhang P, Leak RK, Wang Y, Chen J, Gao Y (2013): Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J Cereb Blood Flow Metab 33: 1474-1484
Stonehouse W, Conion CA, Podd J, Hill SR, Minihane AM, Haskell C, Kennedy C (2013): DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J Clin Nutr 97: 1134-1143
Farooqui AA (2012): n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation. Curr Med Chem 19: 532-543
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R (2012): Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized trial. Brain Behav Immun 26: 988-995
Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, Pikula A, Decarli C, Wolf PA, Vasan RS, Robins SJ, Seshadri S (2012): Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology 78: 658-664
Bazan NG, Molina MF, Gordon WC (2011): Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer`s, and other neurodegenerative diseases. Annu Rev Nutr 31: 321-351
Bradbury J (2011): Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients 3: 529-554
Eckert GP, Chang S, Eckmann J, Copanaki E, Hagl S, Hener U, Müller WE, Kögel D (2011): Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing. Biochem Biophys Acta 1808: 236-243
Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A (2010): Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr 169: 149-164
Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR (2007): Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85:1103-1111
Connor WE, Connor SL (2007): The importance of fish and docosahexaenoic acid in Alzheimer disease. Am J Clin Nutr. 85: 929-930
Hibbeln JR, Ferguson TA, Blasbalg TL (2006): Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention. Int Rev Psychiatry 18: 107-118
Wainwright P (2000): Nutrition and behaviour: The role of n-3 fatty acids in cognitive function. Br J Nutr 83: 337-339
Kyle DJ, Schaefer E, Patton G, Beiser A (1999): Low serum docosahexaenoic acid is a significant risk factor for Alzheimers dementia. Lipids 34: 245

Literatur zu Omega-3-Fettsäuren und Augenfunktion

Meng X-T., Shi Y-Y., Hong-Jan Z. (2022): Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis. Nutr Hosp 39: 910-915
Krueger K., Boehme E., Klettner A.K., Zille M. (2022): The potential of marine resources for retinal diseases: a systematic review of the molecular mechanisms. Crit Rev Food Sci Nutr 62:7518-750
Britten-Jones A.C., Craig J.P., Downie L.E. (2022): Omega-3 polyunsaturated fatty acids and corneal nerve health: Current evidence and future directions. Ocul Surf S1542:0124
Ren J., Ren A., Deng X., Huang Z., Jiang Z., Zhi L., Gong Y. (2022): Long-chain polyunsaturated fatty acids and their metabolites regulate inflammation in age-related macular degeneration. J Inflamm Res 15: 865-880
Csader S., Korhonen S., Kaarniranta K., Schwab U. (2022): The effect of dietary supplementations on delaying the progression of age-related macular degeneration: A systematic review and meta-analysis. Nutrients 14:4273 Jiang H., Shi X., Fan Y., Wand D., Li B., Zhou J., Pei C et al. (2021): Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration. Clin Nutr 40:5663-5673
Rutledge G.A., Pratt S.G., Richer S.P., Huntjens B., Perry C.B., Pratt G., Podella C. (2021): Foveal macular pigment dip in offspring of age-related macular degeneration patients is inversely associated with omega-3 index. BMC Ophtalmol 20:473
Pham T.L., Bazan H.E.P. (2021): Docosanoid signaling modulates corneal nerve regeneration : effect on tear secretion, wound healing, and neuropathic pain. J Lipid Res 62:100033
Pan M., Zhao F., Xie B., Wu H., Zhang S., Ye C., Guan Z., Kang L., Zhang Y., Zhou X., Lei Y., Wang Q., Wang L., Yang F., Zhao C., Qu J., Zhou X. (2021): Dietary ω-3 polyunsaturated fatty acids are protective for myopia. Proc Natl Acad Sci U S A:118:e2104689118
Lafuente M., Gonzalez-Herrero M.E.R., Villadoniga S.R., Domingo J.C. (2021): Antioxidant activity and neuroprotective role of docosahexaenoic acid (DHA) supplementation in eye diseases that can lead to blindness: A narrative review. Antioxidants (Basel) 10:386
Park J., Yoo Y-S., Shin E., Han G., Shin K., Lim D.H., Chung T-Y. (2021): Effects of re-esterified triglyceride (rTG) form of omega-3 supplements on dry eye following cataract surgery. Br J Ophtalmol 105:1504-1509 Pellegrini M., Senni C., Bernabei F., Cicero A.F.G., Vagge A., Maestri A., Scorcia V., Giannaccare G. (2020): The role of nutrition and nutritional supplements in ocular surface diseases. Nutrients 12:952
Terao R., Kaneko H. (2020): Lipid signaling in ocular neovascularization. Int J Mol Sci 21: 4758
Zhang Ac., Singh S., Craig JP., Downie LE. (2020): Omega-3 fatty acids and eye health: Opinions and self-reported practice behaviors of optometrists in Australia and New Zealand. Nutrients 12: 1179
Sugasini D., Yalagala PCR., Subbaiah PV. (2020): Efficient enrichment of retinal DHA with dietary lysophosphatidylcholine-DHA: Potential application for retinopathies. Nutrients 12: 3114
Suzumura A., Terao R., Kaneko H. (2020): Protective effects and molecular signaling of n-3 fatty acids on oxidative stress and inflammation in retinal diseases. Antioxidants 9: 920
de Viteri MS., Hernandez M., Bilbao- Malave V., Fernandez-Robredo P., Gonzalez- Zamora J., Garcia-Garcia L., Ispizua N., Recalde S., Garcia-Layana A. (2020): A higher proportion of eicosapentaenoic acid (EPA) when combined with docosahexaenoic acid (DHA) in omega-3 dietary supplements provides higher antioxidant effects in human retinal cells. Antioxidants 9: 828 Huang CP., Lin YW., Tsai FJ.(2020): Mitochondrial dysfunction as a novel target for neuroprotective nutraceuticals in ocular diseases. Nutrients 12: 1950
Giannaccare G., Pellegrini M., Sebastiani S., Bernabei F., Roda M., Taroni L., Versura P., Campos EC. (2019): Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials. Cornea 38: 565-573
Dartt DA., Hodges RR., Serhan CN. (2019): Immunoresolvent resolvin D1 maintains the health of the ocular surface. Adv Exp Med Biol 1161: 13-25
Kaye R., Botten N., Lippestad M., Li D., Hodges RR., Utheim TP., Serhan CN., Dartt DA. (2019): Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells. Exp Eye Res 180: 53-62
Zhang AC., Downie LE. (2019): Preliminary validation of a food frequency questionnaire to assess long-chain omega-3 fatty acid intake in eye care practice. Nutrients 11: 817 doi: 10. 3390/nu11040817
Meng Y., Liu H-w., Sun P., Zhou P-p., Wang J-j. (2019): Omega-3 and ranibizumab for age-related macular degeneration. A systematic review protocol. Medicine (Baltimore) 98: 13(e14516) Tachikawa M., Akanuma SI., Imai T, Okayasu S., Tomohiro T., Hatanaka Y., Hosoya KI. (2018): Multiple cellular transport and binding processes of unesterified docosahexaenoic acid in outer blood-retinal barrier retinal pigment epithelial cells. Biol Pharm Bull 41:1384-1392
Shindou H., Koso H., Sasaki J.,Nakanishi H., Sagara H., Nakagawa KM., Takahashi Y., Hishikawa D., Lizuka-Hishikawa Y., Tokumasu F., Noguchi H., Watanabe S., Sasaki T., Shimizu T. (2017): Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells. J Biol Chem 292: 12054 – 12064
Gong Y., Fu Z., Liegl R., Chen J., Hellström A., Smith LE. (2017): ω – 3 and ω – 6 long – chain PUFAs and their enzymatic metabolites in neovascular eye diseases. Am J Clin Nutr 106: 16 – 26
Barabino S., Horwath-Winter J., Messmer EM., Rolando M., Aragona P., Kinoshita S. (2017): The role of systemic and topical fatty acids for dry eye treatment. Prog Retin Eye Res, doi:10.1016/j.preteyeres.2017.05.003
Hasegawa E., Inafuku S., Mulki L., Okunuki Y., Yanai R., Smith KE., Kim CB., Klokman G., Bielenberg DR., Puli N., Falck JR., Husain D., Miller JW., Edin ML., Zeldin DC., Lee KSS., Hammock BD., Schunck WH., Connor KM. (2017): Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization. Proc Natl Acad Sci U S A, doi: 10.1073/pnas. 1620898114
Mohammadpour M., Mehrabi S., Hassanpoor N., Mirshahi R. (2016): Effects of adjuvant omega – 3 fatty acid supplementation on dry eye syndrome following cataract surgery: a randomized clinical trial. J Curr Ophthalmol 29: 33 – 38
Tellez – Vazquez J. (2016): Omega – 3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study. Clin Ophthalmol10: 617 – 626
Bhargava R., Chandra M., Bansal U., Singh D., Ranjan S., Sharma S. (2016): A randomized controlled trial of omega – 3 fatty acids in rosacea patients with dry eye symptoms. Curr Eye Res 41:1274 – 1280
Epitropoulos AT., Donnenfeld ED., Shah ZA., Holland EJ., Gross M., Faulkner WJ., Matossian C., Lane SS., Toyos M., Bucci FA Jr., Perry HD (2016): Effect of oral re-esterified omega – 3 nutritional supplementation on dry eyes. Cornea 35: 1185 – 1191
Gatell – Tortajada J. (2016): Oral supplementation with a nutraceutical formulation containing omega – 3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study. Clin Interv Aging 11: 571 – 578
Lawrenson JG., Evans JR. (2015): Omega – 3 fatty acids for preventing or progression of age – related macular degeneration. Cochrane Database Syst Rev 4: CDO10015
Johansson I., Monsen VT., Pettersen K., Mildenberger J., Misund K., Kaarniranta K., Schonberg S., Bjorkoy G. (2015): The marine n – 3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE 2L2 in human retinal pigment epithelial cells. Autophagy 11: 1636 – 1651
Bhargava R, Kumar P (2015): Oral omega-3 fatty acid treatment for dry eye in contact lens wearers. Cornea 34: 413 – 420
Bhargava R, Kumar P, Phogat P, Kaur A, Kumar M (2015): Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Cont Lens Anterior Eye 38: 206 – 210
Korb DR, Blackie CA, Finnemore VM, Douglass T (2015): Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient/evaporative dry eye. Cornea 34: 407 – 412
Merle BMJ, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH (2014): Circulating omega-3 fatty acids and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 55: 2010 – 2019
Olenik A (2014): Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study. Clin Ophthalmol 8:169-176
Liu AJL (2014): Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized studies. Med Sci Monit 20: 1583-1589
Harauma A, Saito J, Watanabe Y, Moriguchi T (2014): Potential for daily supplementation of n-3 fatty acids to reverse symptoms of dry eye in mice. Prostagandins Leukot Essent Fatty Acids 90: 207-213
Merle BM, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH, Nutritional AMD Treatment 2 Study Group (2014): Circulating omega-3 fatty acids and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 55: 2010-2019
Leigh NJ, Nelson JW, Mellas RE, Aquirre A, Baker OJ (2014): Expression of resolvin D1 biosynthetic pathways in salivary epithelium. J Dent Res 93: 300-305
Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A (2013): A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol 6: 811-816
Kawakita T, Kawabata F, Tsuji T, Kawashima M, Shimmura S, Tsubota K (2013): Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomed Res 34: 215-220
Arnold C, Winter L, Fröhlich K, Jentsch S, Dawczynski J, Jahreis G, Böhm V (2013): Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial. JAMA Ophthalmol 131: 564-572
Nguyen CT, Vingrys AJ, Bui BV (2013): Dietary ω-3 deficiency and IOP insult are additive risk factors for ganglion cell dysfunction. J Glaucoma 22: 269-277
Rasmussen HM, Johnson EJ (2013): Nutrients for the aging eye. Clin Interv Aging 8: 741-748
Schleicher M, Weikel K, Garber C, Taylor A (2013): Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients 5: 2405-2456
Hamm M, Neuberger D (2012): Gesunde Augen – ein Leben lang. Wilhelm Goldmann Verlag, München.
Molloy C, Doyle LW, Makrides M, Anderson PJ (2012): Docosahexaenoic acid and visual functioning in preterm infants: a review. Neuropsychol Rev 22: 425-437
Sapieha P, Chen J, Stahl A, Seaward MR, Favazza TL, Juan AM, Hatton CJ, Joyal JS, Krah NM, Dennison RJ, Tang J, Kern TS, Akula JD, Smith LE (2012): Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes 2: 36
Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC (2011): Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study. Arch Ophthalmol 129: 756-766
Huang WB, Fan Q, Zhang XL (2011): Cod liver oil: a potential protective supplement for human glaucoma. Int J Ophthalmol 4: 648-651
Jacques C, Levy E, Muckle G, Jacobson SW, Bastien C, Dewailly E, Ayotte P, Jacobson JL, Saint-Amour D (2011): Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children 158: 83-90
Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE (2010): Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 26: 431-439
Tan JS, Wang JJ, Flood V, Mitchel P (2009): Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 127: 656-665
Cakiner-Egilmez T (2008): Omega 3 fatty acids and the eye. Insight 33: 20-25
Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008): Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126: 826-833
Hodge WG, Barnes D, Schachter HM (2007): Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina 27: 216-221
Robman L, Vu H, Hodge A, Tikellis G, Dimitrov P, McCarty C, Guymer R (2007): Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol 42:720-726
Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P (2006): Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol 124: 981-986
Seddon JM, George S, Rosner B (2006): Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 124: 995-1001
Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA (2005): Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82: 887-893
Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG (2004): A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 137: 704-718
Jeffrey BG, Weisinger HS, Neuringer M, Mitchell DC (2001): The role of docosahexaenoic acid in retinal function. Lipids 36: 859-871
Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE (2001): Essential fatty acids in visual and brain development. Lipids 36: 885-895
Anderson GJ, Connor WE, Corliss JD (1990). Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatric Res 27: 89-97

Literatur-Liste

Literatur zu Omega-3-Fettsäuren: Stoffwechsel, Wirkungen und allgemeine Gesichtspunkte

Literatur zu Omega-3-Fettsäuren und Herz-Kreislauf-Erkrankungen

Omega-3-Fettsäuren und Gehirnfunktion

Literatur zu Omega-3-Fettsäuren und Augenfunktion

Der YouTube-Kanal des Arbeitskreis Omega-3 e.V.

Buchempfehlung zu Omega-3: Omega-3-aktiv

Aktuelles Thema

Stellungnahme des wissenschaftlichen Beirats des Arbeitskreis Omega-3 e. V. zum Thema„Omega-3-Präparate können bei Herzpatienten das Risiko für Vorhofflimmern erhöhen“

Literatur-Liste

Literatur zu Omega-3-Fettsäuren: Stoffwechsel, Wirkungen und allgemeine Gesichtspunkte

Literatur zu Omega-3-Fettsäuren und Herz-Kreislauf-Erkrankungen

Omega-3-Fettsäuren und Gehirnfunktion

Literatur zu Omega-3-Fettsäuren und Augenfunktion

Der YouTube-Kanal des Arbeitskreis Omega-3 e.V.

Buchempfehlung zu Omega-3: Omega-3-aktiv

Aktuelles Thema

Stellungnahme des wissenschaftlichen Beirats des Arbeitskreis Omega-3 e. V. zum Thema„Omega-3-Präparate können bei Herz­patienten das Risiko für Vorhofflimmern erhöhen“

Stellungnahme des wissenschaftlichen Beirats des Arbeitskreis Omega-3 e. V. zum Thema„Omega-3-Präparate können bei Herzpatienten das Risiko für Vorhofflimmern erhöhen“